CN108178797B - A kind of anti-silkworm BmSRC polyclonal antiserum, preparation method and application - Google Patents
A kind of anti-silkworm BmSRC polyclonal antiserum, preparation method and application Download PDFInfo
- Publication number
- CN108178797B CN108178797B CN201711468725.3A CN201711468725A CN108178797B CN 108178797 B CN108178797 B CN 108178797B CN 201711468725 A CN201711468725 A CN 201711468725A CN 108178797 B CN108178797 B CN 108178797B
- Authority
- CN
- China
- Prior art keywords
- bmsrc
- silkworm
- protein
- polyclonal antiserum
- thr
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 12
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 70
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 55
- 241000255789 Bombyx mori Species 0.000 claims abstract description 35
- 238000000034 method Methods 0.000 claims abstract description 17
- 230000014509 gene expression Effects 0.000 claims abstract description 14
- 238000001514 detection method Methods 0.000 claims abstract description 8
- 230000003053 immunization Effects 0.000 claims abstract description 7
- 239000000427 antigen Substances 0.000 claims abstract description 6
- 102000036639 antigens Human genes 0.000 claims abstract description 6
- 108091007433 antigens Proteins 0.000 claims abstract description 6
- 238000002649 immunization Methods 0.000 claims abstract description 4
- 241001465754 Metazoa Species 0.000 claims abstract description 3
- 239000000047 product Substances 0.000 claims description 25
- 239000006228 supernatant Substances 0.000 claims description 19
- 210000004369 blood Anatomy 0.000 claims description 13
- 239000008280 blood Substances 0.000 claims description 13
- 230000003321 amplification Effects 0.000 claims description 12
- 238000003199 nucleic acid amplification method Methods 0.000 claims description 12
- 239000013598 vector Substances 0.000 claims description 12
- 230000009465 prokaryotic expression Effects 0.000 claims description 10
- 230000006698 induction Effects 0.000 claims description 9
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 8
- 238000012408 PCR amplification Methods 0.000 claims description 7
- 239000002299 complementary DNA Substances 0.000 claims description 7
- 239000013604 expression vector Substances 0.000 claims description 6
- 238000001742 protein purification Methods 0.000 claims description 6
- 238000012163 sequencing technique Methods 0.000 claims description 6
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 claims description 6
- 239000012634 fragment Substances 0.000 claims description 5
- 239000000499 gel Substances 0.000 claims description 5
- 239000007788 liquid Substances 0.000 claims description 5
- 210000000056 organ Anatomy 0.000 claims description 5
- 239000008188 pellet Substances 0.000 claims description 5
- 238000000246 agarose gel electrophoresis Methods 0.000 claims description 4
- 229910052757 nitrogen Inorganic materials 0.000 claims description 4
- 238000000137 annealing Methods 0.000 claims description 3
- 238000006243 chemical reaction Methods 0.000 claims description 3
- 238000004925 denaturation Methods 0.000 claims description 3
- 230000036425 denaturation Effects 0.000 claims description 3
- 238000012257 pre-denaturation Methods 0.000 claims description 3
- 241000894006 Bacteria Species 0.000 claims description 2
- 230000001939 inductive effect Effects 0.000 claims description 2
- 230000001131 transforming effect Effects 0.000 claims 2
- 102000004190 Enzymes Human genes 0.000 claims 1
- 108090000790 Enzymes Proteins 0.000 claims 1
- 238000003776 cleavage reaction Methods 0.000 claims 1
- 230000007017 scission Effects 0.000 claims 1
- 238000012795 verification Methods 0.000 claims 1
- 210000004027 cell Anatomy 0.000 abstract description 18
- 241000238631 Hexapoda Species 0.000 abstract description 5
- 241000699670 Mus sp. Species 0.000 abstract description 5
- 238000010166 immunofluorescence Methods 0.000 abstract description 4
- 238000002474 experimental method Methods 0.000 abstract description 3
- 210000001236 prokaryotic cell Anatomy 0.000 abstract description 3
- 230000009193 crawling Effects 0.000 abstract description 2
- 238000001727 in vivo Methods 0.000 abstract description 2
- 235000018102 proteins Nutrition 0.000 description 44
- 210000003000 inclusion body Anatomy 0.000 description 16
- 108020004414 DNA Proteins 0.000 description 15
- 108010078070 scavenger receptors Proteins 0.000 description 15
- 102000014452 scavenger receptors Human genes 0.000 description 15
- 210000001519 tissue Anatomy 0.000 description 9
- 230000001580 bacterial effect Effects 0.000 description 8
- 241000699666 Mus <mouse, genus> Species 0.000 description 7
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- 239000003550 marker Substances 0.000 description 6
- 210000002966 serum Anatomy 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 5
- 239000013612 plasmid Substances 0.000 description 5
- 239000002244 precipitate Substances 0.000 description 5
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 description 4
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 238000005119 centrifugation Methods 0.000 description 4
- 238000010276 construction Methods 0.000 description 4
- 238000013461 design Methods 0.000 description 4
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 239000006180 TBST buffer Substances 0.000 description 3
- COYHRQWNJDJCNA-NUJDXYNKSA-N Thr-Thr-Thr Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O COYHRQWNJDJCNA-NUJDXYNKSA-N 0.000 description 3
- 210000000601 blood cell Anatomy 0.000 description 3
- 230000029087 digestion Effects 0.000 description 3
- 238000001962 electrophoresis Methods 0.000 description 3
- 210000002615 epidermis Anatomy 0.000 description 3
- 210000002468 fat body Anatomy 0.000 description 3
- 210000003128 head Anatomy 0.000 description 3
- 238000000746 purification Methods 0.000 description 3
- 102000005962 receptors Human genes 0.000 description 3
- 108020003175 receptors Proteins 0.000 description 3
- WQKAQKZRDIZYNV-VZFHVOOUSA-N Ala-Ser-Thr Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(O)=O WQKAQKZRDIZYNV-VZFHVOOUSA-N 0.000 description 2
- 241000588724 Escherichia coli Species 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- ANTFEOSJMAUGIB-KNZXXDILSA-N Ile-Thr-Pro Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H]([C@@H](C)O)C(=O)N1CCC[C@@H]1C(=O)O)N ANTFEOSJMAUGIB-KNZXXDILSA-N 0.000 description 2
- 108010007622 LDL Lipoproteins Proteins 0.000 description 2
- 102000007330 LDL Lipoproteins Human genes 0.000 description 2
- LJADEBULDNKJNK-IHRRRGAJSA-N Lys-Leu-Val Chemical compound CC(C)C[C@H](NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](C(C)C)C(O)=O LJADEBULDNKJNK-IHRRRGAJSA-N 0.000 description 2
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
- JWQNAFHCXKVZKZ-UVOCVTCTSA-N Thr-Lys-Thr Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(O)=O JWQNAFHCXKVZKZ-UVOCVTCTSA-N 0.000 description 2
- ZMYCLHFLHRVOEA-HEIBUPTGSA-N Thr-Thr-Ser Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(O)=O ZMYCLHFLHRVOEA-HEIBUPTGSA-N 0.000 description 2
- 102100023935 Transmembrane glycoprotein NMB Human genes 0.000 description 2
- 239000007983 Tris buffer Substances 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 239000002671 adjuvant Substances 0.000 description 2
- 150000001413 amino acids Chemical group 0.000 description 2
- 229960000723 ampicillin Drugs 0.000 description 2
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 239000004202 carbamide Substances 0.000 description 2
- 210000000170 cell membrane Anatomy 0.000 description 2
- NKLPQNGYXWVELD-UHFFFAOYSA-M coomassie brilliant blue Chemical compound [Na+].C1=CC(OCC)=CC=C1NC1=CC=C(C(=C2C=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=2C=CC(=CC=2)N(CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=C1 NKLPQNGYXWVELD-UHFFFAOYSA-M 0.000 description 2
- 235000018417 cysteine Nutrition 0.000 description 2
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 2
- 125000000151 cysteine group Chemical group N[C@@H](CS)C(=O)* 0.000 description 2
- 238000007710 freezing Methods 0.000 description 2
- 230000008014 freezing Effects 0.000 description 2
- 210000002149 gonad Anatomy 0.000 description 2
- 210000002503 granulosa cell Anatomy 0.000 description 2
- 239000003446 ligand Substances 0.000 description 2
- 108010003700 lysyl aspartic acid Proteins 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 238000010839 reverse transcription Methods 0.000 description 2
- 108091005486 scavenger receptor class C Proteins 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 238000010186 staining Methods 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 108091007466 transmembrane glycoproteins Proteins 0.000 description 2
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 2
- 238000001262 western blot Methods 0.000 description 2
- PRDFBSVERLRRMY-UHFFFAOYSA-N 2'-(4-ethoxyphenyl)-5-(4-methylpiperazin-1-yl)-2,5'-bibenzimidazole Chemical compound C1=CC(OCC)=CC=C1C1=NC2=CC=C(C=3NC4=CC(=CC=C4N=3)N3CCN(C)CC3)C=C2N1 PRDFBSVERLRRMY-UHFFFAOYSA-N 0.000 description 1
- 108020005345 3' Untranslated Regions Proteins 0.000 description 1
- 241000023308 Acca Species 0.000 description 1
- 241000256118 Aedes aegypti Species 0.000 description 1
- CXRCVCURMBFFOL-FXQIFTODSA-N Ala-Ala-Pro Chemical compound C[C@H](N)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(O)=O CXRCVCURMBFFOL-FXQIFTODSA-N 0.000 description 1
- BUDNAJYVCUHLSV-ZLUOBGJFSA-N Ala-Asp-Ser Chemical compound C[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(O)=O BUDNAJYVCUHLSV-ZLUOBGJFSA-N 0.000 description 1
- XYTNPQNAZREREP-XQXXSGGOSA-N Ala-Glu-Thr Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O XYTNPQNAZREREP-XQXXSGGOSA-N 0.000 description 1
- JDIQCVUDDFENPU-ZKWXMUAHSA-N Ala-His-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](N)C)CC1=CNC=N1 JDIQCVUDDFENPU-ZKWXMUAHSA-N 0.000 description 1
- OYJCVIGKMXUVKB-GARJFASQSA-N Ala-Leu-Pro Chemical compound C[C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@@H]1C(=O)O)N OYJCVIGKMXUVKB-GARJFASQSA-N 0.000 description 1
- VCSABYLVNWQYQE-SRVKXCTJSA-N Ala-Lys-Lys Chemical compound NCCCC[C@H](NC(=O)[C@@H](N)C)C(=O)N[C@@H](CCCCN)C(O)=O VCSABYLVNWQYQE-SRVKXCTJSA-N 0.000 description 1
- VCSABYLVNWQYQE-UHFFFAOYSA-N Ala-Lys-Lys Natural products NCCCCC(NC(=O)C(N)C)C(=O)NC(CCCCN)C(O)=O VCSABYLVNWQYQE-UHFFFAOYSA-N 0.000 description 1
- NZGRHTKZFSVPAN-BIIVOSGPSA-N Ala-Ser-Pro Chemical compound C[C@@H](C(=O)N[C@@H](CO)C(=O)N1CCC[C@@H]1C(=O)O)N NZGRHTKZFSVPAN-BIIVOSGPSA-N 0.000 description 1
- UISQLSIBJKEJSS-GUBZILKMSA-N Arg-Arg-Ser Chemical compound NC(N)=NCCC[C@H](N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CO)C(O)=O UISQLSIBJKEJSS-GUBZILKMSA-N 0.000 description 1
- BBYTXXRNSFUOOX-IHRRRGAJSA-N Arg-Cys-Phe Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O BBYTXXRNSFUOOX-IHRRRGAJSA-N 0.000 description 1
- YWENWUYXQUWRHQ-LPEHRKFASA-N Arg-Cys-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CS)NC(=O)[C@H](CCCN=C(N)N)N)C(=O)O YWENWUYXQUWRHQ-LPEHRKFASA-N 0.000 description 1
- YNSGXDWWPCGGQS-YUMQZZPRSA-N Arg-Gly-Gln Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(O)=O YNSGXDWWPCGGQS-YUMQZZPRSA-N 0.000 description 1
- OTZMRMHZCMZOJZ-SRVKXCTJSA-N Arg-Leu-Glu Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O OTZMRMHZCMZOJZ-SRVKXCTJSA-N 0.000 description 1
- MJINRRBEMOLJAK-DCAQKATOSA-N Arg-Lys-Asp Chemical compound OC(=O)C[C@@H](C(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCN=C(N)N MJINRRBEMOLJAK-DCAQKATOSA-N 0.000 description 1
- FSPQNLYOFCXUCE-BPUTZDHNSA-N Arg-Trp-Asn Chemical compound C1=CC=C2C(=C1)C(=CN2)C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)[C@H](CCCN=C(N)N)N FSPQNLYOFCXUCE-BPUTZDHNSA-N 0.000 description 1
- ACRYGQFHAQHDSF-ZLUOBGJFSA-N Asn-Asn-Asn Chemical compound NC(=O)C[C@H](N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O ACRYGQFHAQHDSF-ZLUOBGJFSA-N 0.000 description 1
- UDSVWSUXKYXSTR-QWRGUYRKSA-N Asn-Gly-Tyr Chemical compound [H]N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O UDSVWSUXKYXSTR-QWRGUYRKSA-N 0.000 description 1
- KRXIWXCXOARFNT-ZLUOBGJFSA-N Asp-Ala-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC(O)=O KRXIWXCXOARFNT-ZLUOBGJFSA-N 0.000 description 1
- TVVYVAUGRHNTGT-UGYAYLCHSA-N Asp-Asp-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](N)CC(O)=O TVVYVAUGRHNTGT-UGYAYLCHSA-N 0.000 description 1
- PJERDVUTUDZPGX-ZKWXMUAHSA-N Asp-Cys-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@H](CS)NC(=O)[C@@H](N)CC(O)=O PJERDVUTUDZPGX-ZKWXMUAHSA-N 0.000 description 1
- DTNUIAJCPRMNBT-WHFBIAKZSA-N Asp-Gly-Ala Chemical compound [H]N[C@@H](CC(O)=O)C(=O)NCC(=O)N[C@@H](C)C(O)=O DTNUIAJCPRMNBT-WHFBIAKZSA-N 0.000 description 1
- BIVYLQMZPHDUIH-WHFBIAKZSA-N Asp-Gly-Cys Chemical compound C([C@@H](C(=O)NCC(=O)N[C@@H](CS)C(=O)O)N)C(=O)O BIVYLQMZPHDUIH-WHFBIAKZSA-N 0.000 description 1
- RKNIUWSZIAUEPK-PBCZWWQYSA-N Asp-His-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CC1=CN=CN1)NC(=O)[C@H](CC(=O)O)N)O RKNIUWSZIAUEPK-PBCZWWQYSA-N 0.000 description 1
- AITKTFCQOBRJTG-CIUDSAMLSA-N Asp-Leu-Cys Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CS)C(=O)O)NC(=O)[C@H](CC(=O)O)N AITKTFCQOBRJTG-CIUDSAMLSA-N 0.000 description 1
- WOPJVEMFXYHZEE-SRVKXCTJSA-N Asp-Phe-Asp Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(O)=O)C(O)=O WOPJVEMFXYHZEE-SRVKXCTJSA-N 0.000 description 1
- YRZIYQGXTSBRLT-AVGNSLFASA-N Asp-Phe-Gln Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCC(N)=O)C(O)=O YRZIYQGXTSBRLT-AVGNSLFASA-N 0.000 description 1
- GPPIDDWYKJPRES-YDHLFZDLSA-N Asp-Phe-Val Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](C(C)C)C(O)=O GPPIDDWYKJPRES-YDHLFZDLSA-N 0.000 description 1
- AHWRSSLYSGLBGD-CIUDSAMLSA-N Asp-Pro-Glu Chemical compound OC(=O)C[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(O)=O AHWRSSLYSGLBGD-CIUDSAMLSA-N 0.000 description 1
- WMLFFCRUSPNENW-ZLUOBGJFSA-N Asp-Ser-Ala Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(O)=O WMLFFCRUSPNENW-ZLUOBGJFSA-N 0.000 description 1
- MNQMTYSEKZHIDF-GCJQMDKQSA-N Asp-Thr-Ala Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(O)=O MNQMTYSEKZHIDF-GCJQMDKQSA-N 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 208000037260 Atherosclerotic Plaque Diseases 0.000 description 1
- 101710117545 C protein Proteins 0.000 description 1
- 241000283707 Capra Species 0.000 description 1
- SURTWIXUHQNUGN-GUBZILKMSA-N Cys-Arg-Met Chemical compound CSCC[C@@H](C(=O)O)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CS)N SURTWIXUHQNUGN-GUBZILKMSA-N 0.000 description 1
- VZKXOWRNJDEGLZ-WHFBIAKZSA-N Cys-Asp-Gly Chemical compound SC[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)NCC(O)=O VZKXOWRNJDEGLZ-WHFBIAKZSA-N 0.000 description 1
- IIGHQOPGMGKDMT-SRVKXCTJSA-N Cys-Asp-Phe Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CS)N IIGHQOPGMGKDMT-SRVKXCTJSA-N 0.000 description 1
- HIPHJNWPLMUBQQ-ACZMJKKPSA-N Cys-Cys-Gln Chemical compound SC[C@H](N)C(=O)N[C@@H](CS)C(=O)N[C@H](C(O)=O)CCC(N)=O HIPHJNWPLMUBQQ-ACZMJKKPSA-N 0.000 description 1
- AZDQAZRURQMSQD-XPUUQOCRSA-N Cys-Val-Gly Chemical compound [H]N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)NCC(O)=O AZDQAZRURQMSQD-XPUUQOCRSA-N 0.000 description 1
- 102000016911 Deoxyribonucleases Human genes 0.000 description 1
- 108010053770 Deoxyribonucleases Proteins 0.000 description 1
- 241000255601 Drosophila melanogaster Species 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 241000283074 Equus asinus Species 0.000 description 1
- 102100022887 GTP-binding nuclear protein Ran Human genes 0.000 description 1
- WMOMPXKOKASNBK-PEFMBERDSA-N Gln-Asn-Ile Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O WMOMPXKOKASNBK-PEFMBERDSA-N 0.000 description 1
- UWKPRVKWEKEMSY-DCAQKATOSA-N Gln-Lys-Gln Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(O)=O UWKPRVKWEKEMSY-DCAQKATOSA-N 0.000 description 1
- ZGHMRONFHDVXEF-AVGNSLFASA-N Gln-Ser-Phe Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O ZGHMRONFHDVXEF-AVGNSLFASA-N 0.000 description 1
- YRHZWVKUFWCEPW-GLLZPBPUSA-N Gln-Thr-Gln Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)O)NC(=O)[C@H](CCC(=O)N)N)O YRHZWVKUFWCEPW-GLLZPBPUSA-N 0.000 description 1
- PVBBEKPHARMPHX-DCAQKATOSA-N Glu-Gln-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CCC(O)=O PVBBEKPHARMPHX-DCAQKATOSA-N 0.000 description 1
- NKLRYVLERDYDBI-FXQIFTODSA-N Glu-Glu-Asp Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O NKLRYVLERDYDBI-FXQIFTODSA-N 0.000 description 1
- HNVFSTLPVJWIDV-CIUDSAMLSA-N Glu-Glu-Gln Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(O)=O HNVFSTLPVJWIDV-CIUDSAMLSA-N 0.000 description 1
- CUXJIASLBRJOFV-LAEOZQHASA-N Glu-Gly-Ile Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(O)=O CUXJIASLBRJOFV-LAEOZQHASA-N 0.000 description 1
- OFIHURVSQXAZIR-SZMVWBNQSA-N Glu-Lys-Trp Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(O)=O OFIHURVSQXAZIR-SZMVWBNQSA-N 0.000 description 1
- RXESHTOTINOODU-JYJNAYRXSA-N Glu-Phe-His Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CC2=CN=CN2)C(=O)O)NC(=O)[C@H](CCC(=O)O)N RXESHTOTINOODU-JYJNAYRXSA-N 0.000 description 1
- XZRZILPOZBVTDB-GJZGRUSLSA-N Gly-Arg-Trp Chemical compound C1=CC=C2C(C[C@H](NC(=O)[C@H](CCCNC(N)=N)NC(=O)CN)C(O)=O)=CNC2=C1 XZRZILPOZBVTDB-GJZGRUSLSA-N 0.000 description 1
- OCDLPQDYTJPWNG-YUMQZZPRSA-N Gly-Asn-Lys Chemical compound C(CCN)C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)N)NC(=O)CN OCDLPQDYTJPWNG-YUMQZZPRSA-N 0.000 description 1
- FZQLXNIMCPJVJE-YUMQZZPRSA-N Gly-Asp-Leu Chemical compound [H]NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(O)=O FZQLXNIMCPJVJE-YUMQZZPRSA-N 0.000 description 1
- CEXINUGNTZFNRY-BYPYZUCNSA-N Gly-Cys-Gly Chemical compound [NH3+]CC(=O)N[C@@H](CS)C(=O)NCC([O-])=O CEXINUGNTZFNRY-BYPYZUCNSA-N 0.000 description 1
- UEGIPZAXNBYCCP-NKWVEPMBSA-N Gly-Cys-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CS)NC(=O)CN)C(=O)O UEGIPZAXNBYCCP-NKWVEPMBSA-N 0.000 description 1
- HFXJIZNEXNIZIJ-BQBZGAKWSA-N Gly-Glu-Gln Chemical compound NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(O)=O HFXJIZNEXNIZIJ-BQBZGAKWSA-N 0.000 description 1
- NSTUFLGQJCOCDL-UWVGGRQHSA-N Gly-Leu-Arg Chemical compound NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(O)=O)CCCN=C(N)N NSTUFLGQJCOCDL-UWVGGRQHSA-N 0.000 description 1
- VBOBNHSVQKKTOT-YUMQZZPRSA-N Gly-Lys-Ala Chemical compound [H]NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(O)=O VBOBNHSVQKKTOT-YUMQZZPRSA-N 0.000 description 1
- PDUHNKAFQXQNLH-ZETCQYMHSA-N Gly-Lys-Gly Chemical compound NCCCC[C@H](NC(=O)CN)C(=O)NCC(O)=O PDUHNKAFQXQNLH-ZETCQYMHSA-N 0.000 description 1
- YOBGUCWZPXJHTN-BQBZGAKWSA-N Gly-Ser-Arg Chemical compound NCC(=O)N[C@@H](CO)C(=O)N[C@H](C(O)=O)CCCN=C(N)N YOBGUCWZPXJHTN-BQBZGAKWSA-N 0.000 description 1
- FGPLUIQCSKGLTI-WDSKDSINSA-N Gly-Ser-Glu Chemical compound NCC(=O)N[C@@H](CO)C(=O)N[C@H](C(O)=O)CCC(O)=O FGPLUIQCSKGLTI-WDSKDSINSA-N 0.000 description 1
- WCORRBXVISTKQL-WHFBIAKZSA-N Gly-Ser-Ser Chemical compound NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(O)=O WCORRBXVISTKQL-WHFBIAKZSA-N 0.000 description 1
- LCRDMSSAKLTKBU-ZDLURKLDSA-N Gly-Ser-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@H](CO)NC(=O)CN LCRDMSSAKLTKBU-ZDLURKLDSA-N 0.000 description 1
- 101000774835 Heteractis crispa PI-stichotoxin-Hcr2o Proteins 0.000 description 1
- AJTBOTWDSRSUDV-ULQDDVLXSA-N His-Phe-Met Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCSC)C(O)=O AJTBOTWDSRSUDV-ULQDDVLXSA-N 0.000 description 1
- 101000620756 Homo sapiens GTP-binding nuclear protein Ran Proteins 0.000 description 1
- 101001134216 Homo sapiens Macrophage scavenger receptor types I and II Proteins 0.000 description 1
- RWIKBYVJQAJYDP-BJDJZHNGSA-N Ile-Ala-Lys Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CCCCN RWIKBYVJQAJYDP-BJDJZHNGSA-N 0.000 description 1
- GECLQMBTZCPAFY-PEFMBERDSA-N Ile-Gln-Asp Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(=O)O)C(=O)O)N GECLQMBTZCPAFY-PEFMBERDSA-N 0.000 description 1
- WNQKUUQIVDDAFA-ZPFDUUQYSA-N Ile-Gln-Met Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCSC)C(=O)O)N WNQKUUQIVDDAFA-ZPFDUUQYSA-N 0.000 description 1
- DFJJAVZIHDFOGQ-MNXVOIDGSA-N Ile-Glu-Lys Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)O)N DFJJAVZIHDFOGQ-MNXVOIDGSA-N 0.000 description 1
- GVKKVHNRTUFCCE-BJDJZHNGSA-N Ile-Leu-Ser Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)O)N GVKKVHNRTUFCCE-BJDJZHNGSA-N 0.000 description 1
- PZWBBXHHUSIGKH-OSUNSFLBSA-N Ile-Thr-Arg Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H](C(O)=O)CCCN=C(N)N PZWBBXHHUSIGKH-OSUNSFLBSA-N 0.000 description 1
- QHUREMVLLMNUAX-OSUNSFLBSA-N Ile-Thr-Val Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)O)N QHUREMVLLMNUAX-OSUNSFLBSA-N 0.000 description 1
- PRTZQMBYUZFSFA-XEGUGMAKSA-N Ile-Tyr-Gly Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)NCC(=O)O)N PRTZQMBYUZFSFA-XEGUGMAKSA-N 0.000 description 1
- DLEBSGAVWRPTIX-PEDHHIEDSA-N Ile-Val-Ile Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@H](C(O)=O)[C@@H](C)CC DLEBSGAVWRPTIX-PEDHHIEDSA-N 0.000 description 1
- 108010065920 Insulin Lispro Proteins 0.000 description 1
- 102100034343 Integrase Human genes 0.000 description 1
- 238000012449 Kunming mouse Methods 0.000 description 1
- LHSGPCFBGJHPCY-UHFFFAOYSA-N L-leucine-L-tyrosine Natural products CC(C)CC(N)C(=O)NC(C(O)=O)CC1=CC=C(O)C=C1 LHSGPCFBGJHPCY-UHFFFAOYSA-N 0.000 description 1
- SENJXOPIZNYLHU-UHFFFAOYSA-N L-leucyl-L-arginine Natural products CC(C)CC(N)C(=O)NC(C(O)=O)CCCN=C(N)N SENJXOPIZNYLHU-UHFFFAOYSA-N 0.000 description 1
- 108091026898 Leader sequence (mRNA) Proteins 0.000 description 1
- 241000880493 Leptailurus serval Species 0.000 description 1
- QPRQGENIBFLVEB-BJDJZHNGSA-N Leu-Ala-Ile Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O QPRQGENIBFLVEB-BJDJZHNGSA-N 0.000 description 1
- BQSLGJHIAGOZCD-CIUDSAMLSA-N Leu-Ala-Ser Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(O)=O BQSLGJHIAGOZCD-CIUDSAMLSA-N 0.000 description 1
- FIJMQLGQLBLBOL-HJGDQZAQSA-N Leu-Asn-Thr Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O FIJMQLGQLBLBOL-HJGDQZAQSA-N 0.000 description 1
- IASQBRJGRVXNJI-YUMQZZPRSA-N Leu-Cys-Gly Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)NCC(O)=O IASQBRJGRVXNJI-YUMQZZPRSA-N 0.000 description 1
- BOFAFKVZQUMTID-AVGNSLFASA-N Leu-Gln-His Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)N BOFAFKVZQUMTID-AVGNSLFASA-N 0.000 description 1
- RXGLHDWAZQECBI-SRVKXCTJSA-N Leu-Leu-Ser Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(O)=O RXGLHDWAZQECBI-SRVKXCTJSA-N 0.000 description 1
- RZXLZBIUTDQHJQ-SRVKXCTJSA-N Leu-Lys-Asp Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(O)=O)C(O)=O RZXLZBIUTDQHJQ-SRVKXCTJSA-N 0.000 description 1
- SBANPBVRHYIMRR-UHFFFAOYSA-N Leu-Ser-Pro Natural products CC(C)CC(N)C(=O)NC(CO)C(=O)N1CCCC1C(O)=O SBANPBVRHYIMRR-UHFFFAOYSA-N 0.000 description 1
- VDIARPPNADFEAV-WEDXCCLWSA-N Leu-Thr-Gly Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(O)=O VDIARPPNADFEAV-WEDXCCLWSA-N 0.000 description 1
- ILDSIMPXNFWKLH-KATARQTJSA-N Leu-Thr-Ser Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(O)=O ILDSIMPXNFWKLH-KATARQTJSA-N 0.000 description 1
- SXOFUVGLPHCPRQ-KKUMJFAQSA-N Leu-Tyr-Cys Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CS)C(O)=O SXOFUVGLPHCPRQ-KKUMJFAQSA-N 0.000 description 1
- OPTCSTACHGNULU-DCAQKATOSA-N Lys-Cys-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@H](CS)NC(=O)[C@@H](N)CCCCN OPTCSTACHGNULU-DCAQKATOSA-N 0.000 description 1
- YPLVCBKEPJPBDQ-MELADBBJSA-N Lys-Leu-Pro Chemical compound CC(C)C[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CCCCN)N YPLVCBKEPJPBDQ-MELADBBJSA-N 0.000 description 1
- KJIXWRWPOCKYLD-IHRRRGAJSA-N Lys-Lys-Met Chemical compound CSCC[C@@H](C(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)N KJIXWRWPOCKYLD-IHRRRGAJSA-N 0.000 description 1
- QQPSCXKFDSORFT-IHRRRGAJSA-N Lys-Lys-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN QQPSCXKFDSORFT-IHRRRGAJSA-N 0.000 description 1
- BOJYMMBYBNOOGG-DCAQKATOSA-N Lys-Pro-Ala Chemical compound [H]N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(O)=O BOJYMMBYBNOOGG-DCAQKATOSA-N 0.000 description 1
- WGILOYIKJVQUPT-DCAQKATOSA-N Lys-Pro-Asp Chemical compound [H]N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(O)=O)C(O)=O WGILOYIKJVQUPT-DCAQKATOSA-N 0.000 description 1
- LOGFVTREOLYCPF-RHYQMDGZSA-N Lys-Pro-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CCCCN LOGFVTREOLYCPF-RHYQMDGZSA-N 0.000 description 1
- HKXSZKJMDBHOTG-CIUDSAMLSA-N Lys-Ser-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CCCCN HKXSZKJMDBHOTG-CIUDSAMLSA-N 0.000 description 1
- YCJCEMKOZOYBEF-OEAJRASXSA-N Lys-Thr-Phe Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O YCJCEMKOZOYBEF-OEAJRASXSA-N 0.000 description 1
- BDFHWFUAQLIMJO-KXNHARMFSA-N Lys-Thr-Pro Chemical compound C[C@H]([C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CCCCN)N)O BDFHWFUAQLIMJO-KXNHARMFSA-N 0.000 description 1
- RMOKGALPSPOYKE-KATARQTJSA-N Lys-Thr-Ser Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(O)=O RMOKGALPSPOYKE-KATARQTJSA-N 0.000 description 1
- SQRLLZAQNOQCEG-KKUMJFAQSA-N Lys-Tyr-Ser Chemical compound NCCCC[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](CO)C(O)=O)CC1=CC=C(O)C=C1 SQRLLZAQNOQCEG-KKUMJFAQSA-N 0.000 description 1
- 102100034184 Macrophage scavenger receptor types I and II Human genes 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- KYJHWKAMFISDJE-RCWTZXSCSA-N Met-Thr-Met Chemical compound CSCC[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H](C(O)=O)CCSC KYJHWKAMFISDJE-RCWTZXSCSA-N 0.000 description 1
- CULGJGUDIJATIP-STQMWFEESA-N Met-Tyr-Gly Chemical compound CSCC[C@H](N)C(=O)N[C@H](C(=O)NCC(O)=O)CC1=CC=C(O)C=C1 CULGJGUDIJATIP-STQMWFEESA-N 0.000 description 1
- 102000016943 Muramidase Human genes 0.000 description 1
- 108010014251 Muramidase Proteins 0.000 description 1
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
- SITLTJHOQZFJGG-UHFFFAOYSA-N N-L-alpha-glutamyl-L-valine Natural products CC(C)C(C(O)=O)NC(=O)C(N)CCC(O)=O SITLTJHOQZFJGG-UHFFFAOYSA-N 0.000 description 1
- XZFYRXDAULDNFX-UHFFFAOYSA-N N-L-cysteinyl-L-phenylalanine Natural products SCC(N)C(=O)NC(C(O)=O)CC1=CC=CC=C1 XZFYRXDAULDNFX-UHFFFAOYSA-N 0.000 description 1
- PESQCPHRXOFIPX-UHFFFAOYSA-N N-L-methionyl-L-tyrosine Natural products CSCCC(N)C(=O)NC(C(O)=O)CC1=CC=C(O)C=C1 PESQCPHRXOFIPX-UHFFFAOYSA-N 0.000 description 1
- KZNQNBZMBZJQJO-UHFFFAOYSA-N N-glycyl-L-proline Natural products NCC(=O)N1CCCC1C(O)=O KZNQNBZMBZJQJO-UHFFFAOYSA-N 0.000 description 1
- AJHCSUXXECOXOY-UHFFFAOYSA-N N-glycyl-L-tryptophan Natural products C1=CC=C2C(CC(NC(=O)CN)C(O)=O)=CNC2=C1 AJHCSUXXECOXOY-UHFFFAOYSA-N 0.000 description 1
- -1 NGSP1 Proteins 0.000 description 1
- BQVUABVGYYSDCJ-UHFFFAOYSA-N Nalpha-L-Leucyl-L-tryptophan Natural products C1=CC=C2C(CC(NC(=O)C(N)CC(C)C)C(O)=O)=CNC2=C1 BQVUABVGYYSDCJ-UHFFFAOYSA-N 0.000 description 1
- 229930040373 Paraformaldehyde Natural products 0.000 description 1
- 208000037273 Pathologic Processes Diseases 0.000 description 1
- BBDSZDHUCPSYAC-QEJZJMRPSA-N Phe-Ala-Leu Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(O)=O BBDSZDHUCPSYAC-QEJZJMRPSA-N 0.000 description 1
- KIAWKQJTSGRCSA-AVGNSLFASA-N Phe-Asn-Glu Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCC(=O)O)C(=O)O)N KIAWKQJTSGRCSA-AVGNSLFASA-N 0.000 description 1
- KAGCQPSEVAETCA-JYJNAYRXSA-N Phe-Gln-Leu Chemical compound CC(C)C[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](CC1=CC=CC=C1)N KAGCQPSEVAETCA-JYJNAYRXSA-N 0.000 description 1
- WKTSCAXSYITIJJ-PCBIJLKTSA-N Phe-Ile-Asn Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(N)=O)C(O)=O WKTSCAXSYITIJJ-PCBIJLKTSA-N 0.000 description 1
- FQUUYTNBMIBOHS-IHRRRGAJSA-N Phe-Met-Ser Chemical compound CSCC[C@@H](C(=O)N[C@@H](CO)C(=O)O)NC(=O)[C@H](CC1=CC=CC=C1)N FQUUYTNBMIBOHS-IHRRRGAJSA-N 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- MLQVJYMFASXBGZ-IHRRRGAJSA-N Pro-Asn-Tyr Chemical compound C1C[C@H](NC1)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC2=CC=C(C=C2)O)C(=O)O MLQVJYMFASXBGZ-IHRRRGAJSA-N 0.000 description 1
- RYJRPPUATSKNAY-STECZYCISA-N Pro-Ile-Tyr Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)O)NC(=O)[C@@H]2CCCN2 RYJRPPUATSKNAY-STECZYCISA-N 0.000 description 1
- AUQGUYPHJSMAKI-CYDGBPFRSA-N Pro-Ile-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H]1CCCN1 AUQGUYPHJSMAKI-CYDGBPFRSA-N 0.000 description 1
- YAZNFQUKPUASKB-DCAQKATOSA-N Pro-Lys-Cys Chemical compound C1C[C@H](NC1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)O YAZNFQUKPUASKB-DCAQKATOSA-N 0.000 description 1
- PKHDJFHFMGQMPS-RCWTZXSCSA-N Pro-Thr-Arg Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O PKHDJFHFMGQMPS-RCWTZXSCSA-N 0.000 description 1
- CHYAYDLYYIJCKY-OSUNSFLBSA-N Pro-Thr-Ile Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O CHYAYDLYYIJCKY-OSUNSFLBSA-N 0.000 description 1
- GZNYIXWOIUFLGO-ZJDVBMNYSA-N Pro-Thr-Thr Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O GZNYIXWOIUFLGO-ZJDVBMNYSA-N 0.000 description 1
- LEBTWGWVUVJNTA-FKBYEOEOSA-N Pro-Trp-Phe Chemical compound C1C[C@H](NC1)C(=O)N[C@@H](CC2=CNC3=CC=CC=C32)C(=O)N[C@@H](CC4=CC=CC=C4)C(=O)O LEBTWGWVUVJNTA-FKBYEOEOSA-N 0.000 description 1
- UIUWGMRJTWHIJZ-ULQDDVLXSA-N Pro-Tyr-Lys Chemical compound C1C[C@H](NC1)C(=O)N[C@@H](CC2=CC=C(C=C2)O)C(=O)N[C@@H](CCCCN)C(=O)O UIUWGMRJTWHIJZ-ULQDDVLXSA-N 0.000 description 1
- STGVYUTZKGPRCI-GUBZILKMSA-N Pro-Val-Cys Chemical compound SC[C@@H](C(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]1CCCN1 STGVYUTZKGPRCI-GUBZILKMSA-N 0.000 description 1
- 108010076504 Protein Sorting Signals Proteins 0.000 description 1
- 108010003201 RGH 0205 Proteins 0.000 description 1
- 108010092799 RNA-directed DNA polymerase Proteins 0.000 description 1
- 101100393821 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) GSP2 gene Proteins 0.000 description 1
- XNCUYZKGQOCOQH-YUMQZZPRSA-N Ser-Leu-Gly Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)NCC(O)=O XNCUYZKGQOCOQH-YUMQZZPRSA-N 0.000 description 1
- OWCVUSJMEBGMOK-YUMQZZPRSA-N Ser-Lys-Gly Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)NCC(O)=O OWCVUSJMEBGMOK-YUMQZZPRSA-N 0.000 description 1
- CRJZZXMAADSBBQ-SRVKXCTJSA-N Ser-Lys-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CO CRJZZXMAADSBBQ-SRVKXCTJSA-N 0.000 description 1
- LRZLZIUXQBIWTB-KATARQTJSA-N Ser-Lys-Thr Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(O)=O LRZLZIUXQBIWTB-KATARQTJSA-N 0.000 description 1
- FBLNYDYPCLFTSP-IXOXFDKPSA-N Ser-Phe-Thr Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)O)C(O)=O FBLNYDYPCLFTSP-IXOXFDKPSA-N 0.000 description 1
- AZWNCEBQZXELEZ-FXQIFTODSA-N Ser-Pro-Ser Chemical compound OC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(O)=O AZWNCEBQZXELEZ-FXQIFTODSA-N 0.000 description 1
- XQJCEKXQUJQNNK-ZLUOBGJFSA-N Ser-Ser-Ser Chemical compound OC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(O)=O XQJCEKXQUJQNNK-ZLUOBGJFSA-N 0.000 description 1
- XJDMUQCLVSCRSJ-VZFHVOOUSA-N Ser-Thr-Ala Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(O)=O XJDMUQCLVSCRSJ-VZFHVOOUSA-N 0.000 description 1
- PURRNJBBXDDWLX-ZDLURKLDSA-N Ser-Thr-Gly Chemical compound C[C@H]([C@@H](C(=O)NCC(=O)O)NC(=O)[C@H](CO)N)O PURRNJBBXDDWLX-ZDLURKLDSA-N 0.000 description 1
- SNXUIBACCONSOH-BWBBJGPYSA-N Ser-Thr-Ser Chemical compound OC[C@H](N)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@@H](CO)C(O)=O SNXUIBACCONSOH-BWBBJGPYSA-N 0.000 description 1
- VLMIUSLQONKLDV-HEIBUPTGSA-N Ser-Thr-Thr Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O VLMIUSLQONKLDV-HEIBUPTGSA-N 0.000 description 1
- UKKROEYWYIHWBD-ZKWXMUAHSA-N Ser-Val-Asp Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(O)=O)C(O)=O UKKROEYWYIHWBD-ZKWXMUAHSA-N 0.000 description 1
- YEDSOSIKVUMIJE-DCAQKATOSA-N Ser-Val-Leu Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O YEDSOSIKVUMIJE-DCAQKATOSA-N 0.000 description 1
- NAXBBCLCEOTAIG-RHYQMDGZSA-N Thr-Arg-Lys Chemical compound NC(N)=NCCC[C@H](NC(=O)[C@@H](N)[C@H](O)C)C(=O)N[C@@H](CCCCN)C(O)=O NAXBBCLCEOTAIG-RHYQMDGZSA-N 0.000 description 1
- SWIKDOUVROTZCW-GCJQMDKQSA-N Thr-Asn-Ala Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C)C(=O)O)N)O SWIKDOUVROTZCW-GCJQMDKQSA-N 0.000 description 1
- HJOSVGCWOTYJFG-WDCWCFNPSA-N Thr-Glu-Lys Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)O)N)O HJOSVGCWOTYJFG-WDCWCFNPSA-N 0.000 description 1
- XSTGOZBBXFKGHA-YJRXYDGGSA-N Thr-His-His Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)N[C@@H](CC2=CN=CN2)C(=O)O)N)O XSTGOZBBXFKGHA-YJRXYDGGSA-N 0.000 description 1
- XOWKUMFHEZLKLT-CIQUZCHMSA-N Thr-Ile-Ala Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(O)=O XOWKUMFHEZLKLT-CIQUZCHMSA-N 0.000 description 1
- UGFSAPWZBROURT-IXOXFDKPSA-N Thr-Phe-Cys Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CS)C(=O)O)N)O UGFSAPWZBROURT-IXOXFDKPSA-N 0.000 description 1
- GFRIEEKFXOVPIR-RHYQMDGZSA-N Thr-Pro-Lys Chemical compound C[C@@H](O)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(O)=O GFRIEEKFXOVPIR-RHYQMDGZSA-N 0.000 description 1
- KERCOYANYUPLHJ-XGEHTFHBSA-N Thr-Pro-Ser Chemical compound C[C@@H](O)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(O)=O KERCOYANYUPLHJ-XGEHTFHBSA-N 0.000 description 1
- GVMXJJAJLIEASL-ZJDVBMNYSA-N Thr-Pro-Thr Chemical compound C[C@@H](O)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(O)=O GVMXJJAJLIEASL-ZJDVBMNYSA-N 0.000 description 1
- RVMNUBQWPVOUKH-HEIBUPTGSA-N Thr-Ser-Thr Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(O)=O RVMNUBQWPVOUKH-HEIBUPTGSA-N 0.000 description 1
- NHQVWACSJZJCGJ-FLBSBUHZSA-N Thr-Thr-Ile Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O NHQVWACSJZJCGJ-FLBSBUHZSA-N 0.000 description 1
- CSNBWOJOEOPYIJ-UVOCVTCTSA-N Thr-Thr-Lys Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(O)=O CSNBWOJOEOPYIJ-UVOCVTCTSA-N 0.000 description 1
- FYBFTPLPAXZBOY-KKHAAJSZSA-N Thr-Val-Asp Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(O)=O)C(O)=O FYBFTPLPAXZBOY-KKHAAJSZSA-N 0.000 description 1
- AKHDFZHUPGVFEJ-YEPSODPASA-N Thr-Val-Gly Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)NCC(O)=O AKHDFZHUPGVFEJ-YEPSODPASA-N 0.000 description 1
- ILUOMMDDGREELW-OSUNSFLBSA-N Thr-Val-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](N)[C@@H](C)O ILUOMMDDGREELW-OSUNSFLBSA-N 0.000 description 1
- 108091036066 Three prime untranslated region Proteins 0.000 description 1
- YLGQHMHKAASRGJ-WDSOQIARSA-N Trp-Leu-Met Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CCSC)C(=O)O)NC(=O)[C@H](CC1=CNC2=CC=CC=C21)N YLGQHMHKAASRGJ-WDSOQIARSA-N 0.000 description 1
- RWAYYYOZMHMEGD-XIRDDKMYSA-N Trp-Leu-Ser Chemical compound C1=CC=C2C(C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(O)=O)=CNC2=C1 RWAYYYOZMHMEGD-XIRDDKMYSA-N 0.000 description 1
- ZHZLQVLQBDBQCQ-WDSOQIARSA-N Trp-Lys-Arg Chemical compound C1=CC=C2C(=C1)C(=CN2)C[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)N ZHZLQVLQBDBQCQ-WDSOQIARSA-N 0.000 description 1
- ILTXFANLDMJWPR-SIUGBPQLSA-N Tyr-Ile-Glu Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)O)NC(=O)[C@H](CC1=CC=C(C=C1)O)N ILTXFANLDMJWPR-SIUGBPQLSA-N 0.000 description 1
- HHFMNAVFGBYSAT-IGISWZIWSA-N Tyr-Ile-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)O)NC(=O)[C@H](CC1=CC=C(C=C1)O)N HHFMNAVFGBYSAT-IGISWZIWSA-N 0.000 description 1
- VPEFOFYNHBWFNQ-UFYCRDLUSA-N Tyr-Pro-Tyr Chemical compound C([C@H](N)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(O)=O)C1=CC=C(O)C=C1 VPEFOFYNHBWFNQ-UFYCRDLUSA-N 0.000 description 1
- QPOUERMDWKKZEG-HJPIBITLSA-N Tyr-Ser-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 QPOUERMDWKKZEG-HJPIBITLSA-N 0.000 description 1
- AFWXOGHZEKARFH-ACRUOGEOSA-N Tyr-Tyr-His Chemical compound C([C@H](N)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CC=1NC=NC=1)C(O)=O)C1=CC=C(O)C=C1 AFWXOGHZEKARFH-ACRUOGEOSA-N 0.000 description 1
- 108091023045 Untranslated Region Proteins 0.000 description 1
- MHAHQDBEIDPFQS-NHCYSSNCSA-N Val-Glu-Met Chemical compound CSCC[C@@H](C(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](N)C(C)C MHAHQDBEIDPFQS-NHCYSSNCSA-N 0.000 description 1
- AEMPCGRFEZTWIF-IHRRRGAJSA-N Val-Leu-Lys Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(O)=O AEMPCGRFEZTWIF-IHRRRGAJSA-N 0.000 description 1
- JAKHAONCJJZVHT-DCAQKATOSA-N Val-Lys-Ser Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)O)N JAKHAONCJJZVHT-DCAQKATOSA-N 0.000 description 1
- MJOUSKQHAIARKI-JYJNAYRXSA-N Val-Phe-Val Chemical compound CC(C)[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](C(C)C)C(O)=O)CC1=CC=CC=C1 MJOUSKQHAIARKI-JYJNAYRXSA-N 0.000 description 1
- OFTXTCGQJXTNQS-XGEHTFHBSA-N Val-Thr-Ser Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CO)C(=O)O)NC(=O)[C@H](C(C)C)N)O OFTXTCGQJXTNQS-XGEHTFHBSA-N 0.000 description 1
- DOBHJKVVACOQTN-DZKIICNBSA-N Val-Tyr-Gln Chemical compound NC(=O)CC[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)C(C)C)CC1=CC=C(O)C=C1 DOBHJKVVACOQTN-DZKIICNBSA-N 0.000 description 1
- 108010022164 acetyl-LDL Proteins 0.000 description 1
- 108010087924 alanylproline Proteins 0.000 description 1
- 125000000539 amino acid group Chemical group 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000001640 apoptogenic effect Effects 0.000 description 1
- 230000025194 apoptotic cell clearance Effects 0.000 description 1
- 108010069205 aspartyl-phenylalanine Proteins 0.000 description 1
- 108010038633 aspartylglutamate Proteins 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 210000005252 bulbus oculi Anatomy 0.000 description 1
- 210000004899 c-terminal region Anatomy 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000021164 cell adhesion Effects 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 229960005091 chloramphenicol Drugs 0.000 description 1
- WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 description 1
- 210000000349 chromosome Anatomy 0.000 description 1
- 210000000805 cytoplasm Anatomy 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 239000012154 double-distilled water Substances 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 108010063718 gamma-glutamylaspartic acid Proteins 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 108010078144 glutaminyl-glycine Proteins 0.000 description 1
- VPZXBVLAVMBEQI-UHFFFAOYSA-N glycyl-DL-alpha-alanine Natural products OC(=O)C(C)NC(=O)CN VPZXBVLAVMBEQI-UHFFFAOYSA-N 0.000 description 1
- HPAIKDPJURGQLN-UHFFFAOYSA-N glycyl-L-histidyl-L-phenylalanine Natural products C=1C=CC=CC=1CC(C(O)=O)NC(=O)C(NC(=O)CN)CC1=CN=CN1 HPAIKDPJURGQLN-UHFFFAOYSA-N 0.000 description 1
- XBGGUPMXALFZOT-UHFFFAOYSA-N glycyl-L-tyrosine hemihydrate Natural products NCC(=O)NC(C(O)=O)CC1=CC=C(O)C=C1 XBGGUPMXALFZOT-UHFFFAOYSA-N 0.000 description 1
- 108010087823 glycyltyrosine Proteins 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 108010036413 histidylglycine Proteins 0.000 description 1
- 238000000265 homogenisation Methods 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 108010027338 isoleucylcysteine Proteins 0.000 description 1
- 108010053037 kyotorphin Proteins 0.000 description 1
- 108010044311 leucyl-glycyl-glycine Proteins 0.000 description 1
- 108010090333 leucyl-lysyl-proline Proteins 0.000 description 1
- 108010073472 leucyl-prolyl-proline Proteins 0.000 description 1
- 108010000761 leucylarginine Proteins 0.000 description 1
- 108010057821 leucylproline Proteins 0.000 description 1
- 108010012058 leucyltyrosine Proteins 0.000 description 1
- 239000004325 lysozyme Substances 0.000 description 1
- 229960000274 lysozyme Drugs 0.000 description 1
- 235000010335 lysozyme Nutrition 0.000 description 1
- 108010017391 lysylvaline Proteins 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 229910001629 magnesium chloride Inorganic materials 0.000 description 1
- 108010005942 methionylglycine Proteins 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 238000011022 operating instruction Methods 0.000 description 1
- 210000001672 ovary Anatomy 0.000 description 1
- 229920002866 paraformaldehyde Polymers 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000009054 pathological process Effects 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 210000004180 plasmocyte Anatomy 0.000 description 1
- 229920000447 polyanionic polymer Polymers 0.000 description 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- 108010031719 prolyl-serine Proteins 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000000527 sonication Methods 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 210000001550 testis Anatomy 0.000 description 1
- 238000010257 thawing Methods 0.000 description 1
- 108010061238 threonyl-glycine Proteins 0.000 description 1
- 108010072986 threonyl-seryl-lysine Proteins 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/70—Vectors or expression systems specially adapted for E. coli
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Zoology (AREA)
- Hematology (AREA)
- Microbiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- General Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Urology & Nephrology (AREA)
- Wood Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Plant Pathology (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Peptides Or Proteins (AREA)
Abstract
本发明涉及一种抗家蚕BmSRC多克隆抗血清、制备方法及应用,该方法包括采用SEQ ID NO:1所示序列表示的抗原通过动物免疫获得所述抗家蚕BmSRC多克隆抗血清。根据上述的制备方法制备的抗家蚕BmSRC多克隆抗血清,能够用于检测鳞翅目昆虫中保守的SRC蛋白。本发明成功克隆家蚕BmSRC基因,原核表达纯化出有活性的蛋白,通过多次免疫小鼠产生多克隆抗血清,可以进行体内BmSRC蛋白表达水平的western检测,细胞爬片的免疫荧光等实验。这些都为进行家蚕BmSRC蛋白以及鳞翅目昆虫中保守的SRC蛋白的功能研究提供了有利的工具。
The invention relates to an anti-silkworm BmSRC polyclonal antiserum, a preparation method and an application. The method comprises using the antigen represented by the sequence shown in SEQ ID NO: 1 to obtain the anti-silkworm BmSRC polyclonal antiserum through animal immunization. The anti-Bombyx mori BmSRC polyclonal antiserum prepared according to the above preparation method can be used to detect the conserved SRC protein in Lepidopteran insects. The method successfully clones the silkworm BmSRC gene, expresses and purifies the active protein in prokaryotic cells, and produces polyclonal antiserum by immunizing mice for many times, and can carry out experiments such as western detection of BmSRC protein expression level in vivo, and immunofluorescence of cell crawling films. All these provide useful tools for the functional study of silkworm BmSRC proteins and conserved SRC proteins in lepidopteran insects.
Description
技术领域technical field
本发明涉及多克隆抗血清,并且更具体地,涉及到一种抗家蚕BmSRC多克隆抗血清、制备方法及应用。The present invention relates to polyclonal antiserum, and more particularly, to an anti-silkworm BmSRC polyclonal antiserum, preparation method and application.
背景技术Background technique
清道夫受体(scavenger receptor,SR)是一种位于细胞表面的跨膜糖蛋白,属于受体超基因家族,是一种多功能受体。该受体识别的配体非常广泛,包括能结合修饰性LDL和特定的聚阴离子配体的不同基因产物。主要是识别多聚阴离子,包括天然的和修饰的低密度脂蛋白、凋亡细胞和病原体等。其参与机体一系列的生理和病理过程,包括动脉粥样硬化形成或保护宿主免疫损害防御、细胞粘附、凋亡细胞清除、组织保护和细胞增殖等。1979年Goldstein等首次发现小鼠动脉粥样硬化斑块的巨噬细胞上存在摄取和降解乙酰化低密度脂蛋白的结合位点,后来被称为巨噬细胞清道夫受体1,这是最早发现的清道夫受体。随后陆续发现了其他一些清道夫受体,他们共同组成了清道夫受体家族。根据结构域的不同,清道夫受体被分成了10种类型:清道夫受体A-J(scavenger receptor,A-J)。根据氨基酸结构的不同将SR分为两种亚型,两型稍有区别:Ⅰ型含一个半胱氨酸区,而Ⅱ型则不含有半胱氨酸区,两型的SR基本功能相同。C类清道夫受体(SRC)是包含若干不同结构域的Ⅰ型跨膜糖蛋白,并且位于细胞质膜的外表面上,其C末端区域在细胞质中。SRC已经在几种无脊椎动物,如黑腹果蝇和埃及伊蚊中鉴定,然而SRC尚未在哺乳动物中被发现。Scavenger receptor (SR) is a transmembrane glycoprotein located on the cell surface. It belongs to the receptor supergene family and is a multifunctional receptor. The receptor recognizes a wide range of ligands, including different gene products that bind modified LDL and specific polyanionic ligands. It mainly recognizes polyanions, including natural and modified low-density lipoproteins, apoptotic cells and pathogens. It is involved in a series of physiological and pathological processes in the body, including atherosclerosis formation or protection against host immune damage, cell adhesion, apoptotic cell clearance, tissue protection, and cell proliferation. In 1979, Goldstein et al. first discovered that there is a binding site for the uptake and degradation of acetylated low-density lipoprotein on the macrophages of mouse atherosclerotic plaques, which was later called
发明内容SUMMARY OF THE INVENTION
本发明针对上述问题,目的在于提供一种抗家蚕BmSRC多克隆抗血清、制备方法及应用。In view of the above problems, the present invention aims to provide an anti-Bombyx mori BmSRC polyclonal antiserum, a preparation method and an application.
为达到上述目的,本发明采用如下技术方案:To achieve the above object, the present invention adopts the following technical solutions:
一方面,本发明的实施例公开了一种抗家蚕BmSRC多克隆抗血清的制备方法,其包括采用SEQ ID NO:1所示序列表示的抗原通过动物免疫获得所述抗家蚕BmSRC多克隆抗血清。On the one hand, an embodiment of the present invention discloses a method for preparing an anti-silkworm BmSRC polyclonal antiserum, which comprises obtaining the anti-silkworm BmSRC polyclonal antiserum through animal immunization using an antigen represented by the sequence shown in SEQ ID NO: 1 .
进一步地,所述抗原通过下述步骤制得:Further, the antigen is prepared by the following steps:
(1)提取家蚕总RNA并反转录得到cDNA;(1) Extracting silkworm total RNA and reverse transcription to obtain cDNA;
(2)根据SilkDB提供的SEQ ID NO:3所示预测目标基因序列和EST序列,设计如SEQID NO:7-10所示的扩增引物,获得第一扩增产物;(2) According to the predicted target gene sequence and EST sequence shown in SEQ ID NO: 3 provided by SilkDB, design amplification primers shown in SEQ ID NO: 7-10 to obtain the first amplification product;
所述第一扩增产物与第一连接载体连接后获得第一连接产物,转化第一感受态细胞,获得第一阳性克隆,对第一阳性克隆进行测序验证,测序获得的BmSRC全长编码基因序列如SEQ ID NO:6所示;After the first amplification product is connected with the first connection vector, the first connection product is obtained, the first competent cell is transformed, the first positive clone is obtained, the first positive clone is sequenced and verified, and the BmSRC full-length coding gene obtained by sequencing The sequence is shown in SEQ ID NO: 6;
(3)家蚕BmSRC的原核表达及蛋白纯化(3) Prokaryotic expression and protein purification of silkworm BmSRC
选取BmSRC特异性片段,获得SEQ ID NO:1所示的序列,设计带有Hindlll和xhoI酶切位点的引物进行PCR扩增,获得第二扩增产物;Select the BmSRC specific fragment to obtain the sequence shown in SEQ ID NO: 1, and design primers with Hindlll and xhoI restriction sites to carry out PCR amplification to obtain the second amplification product;
所述第二扩增产物与第二连接载体连接后获得第二连接产物,所述第二连接产物转化第二感受态细胞,进行蛋白诱导表达;After the second amplification product is connected with the second connection vector, a second connection product is obtained, and the second connection product is transformed into a second competent cell to induce protein expression;
对诱导表达的蛋白进行纯化处理,得到所述抗原。Purify the induced expression protein to obtain the antigen.
进一步地,所述带有Hindlll和xhoI酶切位点的引物序列为如SEQ IDNO:11-16所示的序列。Further, the primer sequences with Hindll1 and xhoI restriction sites are the sequences shown in SEQ ID NOs: 11-16.
进一步地,所述第一连接载体为PMD19-T Simple载体,所述第一感受态细胞为Trans1-T1Phage Resistant感受态细胞。Further, the first linking vector is PMD19-T Simple vector, and the first competent cell is Trans1-T1Phage Resistant competent cell.
进一步地,所述第二连接载体为pET32a原核表达载体,所述第二感受态细胞为Rosetta菌株感受态,第一连接产物为PET32a-SRC。Further, the second connection vector is pET32a prokaryotic expression vector, the second competent cell is Rosetta strain competent, and the first connection product is PET32a-SRC.
进一步地,所述蛋白诱导表达包括将诱导完成的菌体破碎后,对分别收集的上清液和沉淀进行SDS-PAGE电泳,其中,分离胶浓度和收缩胶浓度分别为10%和5%。Further, the inducible expression of the protein includes disrupting the induced cells, and performing SDS-PAGE electrophoresis on the collected supernatant and the precipitate, wherein the separation gel concentration and the shrinkage gel concentration are 10% and 5%, respectively.
进一步地,家蚕BmSRC的原核表达及蛋白纯化中,所述PCR扩增反应条件为:94℃预变性2分钟,然后94℃变性30秒、55℃退火30秒、72℃延伸1分钟,循环25次,最后72℃延伸10分钟,得到的PCR产物经琼脂糖凝胶电泳鉴定并回收。Further, in the prokaryotic expression and protein purification of Bombyx mori BmSRC, the PCR amplification reaction conditions were: pre-denaturation at 94°C for 2 minutes, then denaturation at 94°C for 30 seconds, annealing at 55°C for 30 seconds, and extension at 72°C for 1 minute, cycle 25. Second, the final extension at 72°C for 10 minutes, the obtained PCR product was identified and recovered by agarose gel electrophoresis.
进一步地,提取家蚕总RNA的方法为:取家蚕五龄三天幼虫获得组织器官,以及从四龄三天到上簇2天的血液,将所述血液和液氮研磨后的组织器官分别加入Trizol,并分别提取RNA。Further, the method for extracting the total RNA of silkworm is: take the fifth instar three-day larvae of silkworm to obtain tissues and organs, and from the fourth instar three days to the
本发明还提供了上述的制备方法制备的抗家蚕BmSRC多克隆抗血清。The present invention also provides the anti-silkworm BmSRC polyclonal antiserum prepared by the above-mentioned preparation method.
根据上述的制备方法制备的抗家蚕BmSRC多克隆抗血清,能够用于检测鳞翅目昆虫中保守的SRC蛋白。The anti-Bombyx mori BmSRC polyclonal antiserum prepared according to the above preparation method can be used to detect the conserved SRC protein in Lepidopteran insects.
本发明的有益效果是:The beneficial effects of the present invention are:
本发明成功克隆家蚕BmSRC基因,原核表达纯化出有活性的蛋白,通过多次免疫小鼠产生多克隆抗血清,可以进行体内BmSRC蛋白表达水平的western检测,细胞爬片的免疫荧光等实验。这些都为进行家蚕BmSRC蛋白以及鳞翅目昆虫中保守的SRC蛋白的功能研究提供了有利的工具。The method successfully clones the silkworm BmSRC gene, expresses and purifies the active protein in prokaryotic cells, and produces polyclonal antiserum by immunizing mice for many times, and can carry out experiments such as western detection of BmSRC protein expression level in vivo, and immunofluorescence of cell crawling films. All these provide useful tools for the functional study of silkworm BmSRC proteins and conserved SRC proteins in lepidopteran insects.
附图说明Description of drawings
图1A-图1D是家蚕C类清道夫受体基因BmSRC的全长克隆;Figures 1A-1D are full-length clones of the silkworm class C scavenger receptor gene BmSRC;
其中,图1A:BmSRC的大片段PCR产物,图1B:BmSRC的5′RACE产物,图1C:BmSRC的3′RACE产物,图1D:BmSRC的全长。Among them, Figure 1A: large fragment PCR product of BmSRC, Figure 1B: 5'RACE product of BmSRC, Figure 1C: 3'RACE product of BmSRC, Figure 1D: full length of BmSRC.
图2A-图2F是家蚕BmSRC原核表达载体构建及蛋白纯化;Fig. 2A-Fig. 2F are the construction and protein purification of silkworm BmSRC prokaryotic expression vector;
其中,图2A为T-BmSRC载体构建,M:Marker;1:T-Simple空质粒;2:T-BmSRC质粒;3:T-BmSRC使用HindIII和XhoI双酶切验证;4:BmSRC酶切回收片段;Among them, Figure 2A is the construction of T-BmSRC vector, M: Marker; 1: T-Simple empty plasmid; 2: T-BmSRC plasmid; 3: T-BmSRC was verified by double digestion with HindIII and XhoI; 4: BmSRC digestion recovery fragment;
图2B为PET32a-BmSRC原核表达载体构建,M:Marker;1:PET32a空质粒;2:PET32a-BmSRC质粒;3:PET32a-BmSRC使用HindIII和XhoI双酶切验证;Figure 2B shows the construction of the PET32a-BmSRC prokaryotic expression vector, M: Marker; 1: PET32a empty plasmid; 2: PET32a-BmSRC plasmid; 3: PET32a-BmSRC was verified by double digestion with HindIII and XhoI;
图2C为BmSRC在大肠杆菌中终浓度1mmol·L-1的IPTG时不同温度的诱导表达,M:Marker;1:未诱导的上清蛋白;2:未诱导的包涵体蛋白;3:1mmol·L-1IPTG 16℃诱导的上清蛋白;4:1mmol·L-1IPTG16℃诱导的包涵体蛋白;5:1mmol·L-1IPTG 25℃诱导的上清蛋白;6:1mmol·L-1IPTG 25℃诱导的包涵体蛋白;7:1mmol·L-1IPTG 37℃诱导的上清蛋白;8:1mmol·L-1IPTG 37℃诱导的包涵体蛋白;Figure 2C shows the induced expression of BmSRC in E. coli with IPTG at a final concentration of 1 mmol·L-1 at different temperatures, M: Marker; 1: Uninduced supernatant protein; 2: Uninduced inclusion body protein; 3: 1 mmol·L Supernatant protein induced by L-1IPTG at 16°C; 4: Inclusion body protein induced by 1mmol·L-1IPTG at 16°C; 5: Supernatant protein induced by 1mmol·L-1IPTG at 25°C; 6: Induction by 1mmol·L-1IPTG at 25°C 7: Supernatant protein induced by 1mmol·L-1IPTG at 37℃; 8: Inclusion body protein induced by 1mmol·L-1IPTG at 37℃;
图2D为BmSRC在大肠杆菌中37℃时不同IPTG浓度的诱导表达,M:Marker;1:0mmol·L-1IPTG 37℃诱导的上清蛋白;2:0mmol·L-1IPTG 37℃诱导的包涵体蛋白;3:0.1mmol·L-1IPTG 37℃诱导的上清蛋白;4:0.1mmol·L-1IPTG 37℃诱导的包涵体蛋白;5:0.2mmol·L-1IPTG 37℃诱导的上清蛋白;6:0.2mmol·L-1IPTG 37℃诱导的包涵体蛋白;7:0.4mmol·L-1IPTG 37℃诱导的上清蛋白;8:0.4mmol·L-1IPTG 37℃诱导的包涵体蛋白;9:0.6mmol·L-1IPTG 37℃诱导的上清蛋白;10:0.6mmol·L-1IPTG 37℃诱导的包涵体蛋白;11:0.8mmol·L-1IPTG 37℃诱导的上清蛋白;12:0.8mmol·L-1IPTG 37℃诱导的包涵体蛋白;13:1mmol·L-1IPTG 37℃诱导的上清蛋白;14:1mmol·L-1IPTG 37℃诱导的包涵体蛋白;Figure 2D shows the induced expression of BmSRC in E. coli at 37°C with different IPTG concentrations, M: Marker; 1: supernatant protein induced by 0mmol·L-1IPTG at 37°C; 2: inclusion bodies induced by 0mmol·L-1IPTG at 37°C protein; 3: supernatant protein induced by 0.1mmol·L-1IPTG at 37℃; 4: inclusion body protein induced by 0.1mmol·L-1IPTG at 37℃; 5: supernatant protein induced by 0.2mmol·L-1IPTG at 37℃; 6: Inclusion body protein induced by 0.2mmol·L-1IPTG at 37°C; 7: Supernatant protein induced by 0.4mmol·L-1IPTG at 37°C; 8: Inclusion body protein induced by 0.4mmol·L-1IPTG at 37°C; 9: 0.6mmol·L-1IPTG-induced supernatant protein at 37℃; 10: 0.6mmol·L-1IPTG-induced inclusion body protein at 37℃; 11: 0.8mmol·L-1IPTG-induced supernatant protein at 37℃; 12: 0.8mmol ·Inclusion body protein induced by L-1IPTG at 37°C; 13: Supernatant protein induced by 1mmol·L-1IPTG at 37°C; 14: Inclusion body protein induced by 1mmol·L-1IPTG at 37°C;
图2E为BmSRC重组蛋白纯化,M:Marker;1:未进行诱导的上清蛋白;2.未进行诱导的包涵体蛋白;3:0.1mmol·L-1IPTG大规模诱导的上清蛋白;4:0.1mmol·L-1IPTG大规模诱导的包涵体蛋白;Figure 2E is the purification of BmSRC recombinant protein, M: Marker; 1: supernatant protein without induction; 2. inclusion body protein without induction; 3: supernatant protein induced by 0.1 mmol·L-1IPTG on a large scale; 4: 0.1mmol·L-1IPTG large-scale induced inclusion body protein;
图2F为纯化后得到的BmSRC蛋白。M:Marker;5:纯化得到的包涵体蛋白。Figure 2F shows the BmSRC protein obtained after purification. M: Marker; 5: Purified inclusion body protein.
图3A-图3B为抗家蚕BmSRC蛋白血清的检测;Figure 3A-Figure 3B is the detection of anti-silkworm BmSRC protein serum;
其中,图3A为Western blot检测BmSRC蛋白在5龄3天各组织的表达情况。Mi:中肠;Ha:血液;Ge:生殖腺;Fa:脂肪体;Ma:马氏管;Ep:表皮;He:头;Among them, Figure 3A is the Western blot detection of BmSRC protein expression in each tissue at 5 days and 3 days. Mi: midgut; Ha: blood; Ge: gonad; Fa: fat body; Ma: Malpighian duct; Ep: epidermis; He: head;
图3B为免疫荧光检测BmSRC在血液中的表达情况,Gr:颗粒细胞;Oe:拟浆细胞;Pl:浆细胞。Figure 3B shows the expression of BmSRC in blood detected by immunofluorescence, Gr: granulosa cells; Oe: pseudoplasma cells; Pl: plasma cells.
具体实施方式Detailed ways
为了使本发明的目的、技术方案及优点更加清楚明白,下面结合附图及实施例,对本发明进行进一步详细说明。应当理解,此处所描述的具体实施例仅用以解释本发明,并不用于限定本发明。In order to make the objectives, technical solutions and advantages of the present invention clearer, the present invention will be further described in detail below with reference to the accompanying drawings and embodiments. It should be understood that the specific embodiments described herein are only used to explain the present invention, but not to limit the present invention.
实施例1 总RNA的提取和cDNA的合成Example 1 Extraction of total RNA and synthesis of cDNA
解剖家蚕五龄三天幼虫获得头部、表皮、中肠、丝腺、脂肪体、马氏管、精巢、卵巢和血液等组织器官以及从四龄三天到上簇2天的血液,除血液直接加入Trizol外,其他各组织均经液氮研磨后加入Trizo,血液和其他组织分两次加入Trizol,分别操作提取RNA,按照Invitrogen公司TotalRNA操作指南提取总RNA,按照反转录试剂盒说明书采用M-MLV反转录酶系统反转录得到cDNA。The third instar larvae of the silkworm were dissected to obtain the head, epidermis, midgut, silk gland, fat body, Malpighian duct, testis, ovary, blood and other tissues and organs, as well as blood from the fourth instar three days to the upper cluster two days. In addition to adding Trizol directly, other tissues were ground with liquid nitrogen and then added with Trizol. Blood and other tissues were added to Trizol in two separate operations to extract RNA. Total RNA was extracted according to Invitrogen's TotalRNA operation guide, and the reverse transcription kit was used according to the instructions. M-MLV reverse transcriptase system was reverse transcribed to obtain cDNA.
实施例2 RACE法扩增家蚕清道夫受体BmSRC的5′末端序列和3′末端序列Example 2 Amplification of the 5' end sequence and 3' end sequence of the silkworm scavenger receptor BmSRC by RACE method
根据家蚕基因组数据库SilkDB(http://www.silkdb.org/silkdb/)提供的如SEQNO:2所示的预测的目标基因序列和EST序列,相应的氨基酸序列如SEQ ID NO:1所示,依据引物设计原则用Primer 5.0软件设计引物。扩增得到基因的部分中间序列。经测序验证正确后,根据此序列设计基因特异引物GSP1、NGSP1、GSP2、NGSP2,基因的引物序列见表1,SEQNO:7-10。随后按照RACE试剂盒进行5′和3′RACE扩增。扩增产物经1%琼脂糖凝胶电泳检测,回收并连接到PMD19-T Simple载体上,转化,筛选阳性克隆并送华大基因测序,分析拼接后得到cDNA序列,如SEQ NO:6,5′末端序列测序结果如SEQ NO:4,3′末端序列测序结果SEQNO:5。结果如图1A-图1D所示。在家蚕基因组数据库中对应的基因编号为BGIBMGA004577-TA,位于27号染色体上,其scaffold为nscaf2800,位置从531837到541893,该基因的cDNA全长序列为2047bp,含有1个长为1821bp的完整开放阅读框(ORF),共编码606个氨基酸残基,其5′和3′非翻译区序列(UTR)长度分别为399bp和693bp,在3′-UTR结构区域中含有1个加尾信号序列AATAAA。According to the predicted target gene sequence and EST sequence shown in SEQ NO: 2 provided by the silkworm genome database SilkDB (http://www.silkdb.org/silkdb/), the corresponding amino acid sequence is shown in SEQ ID NO: 1, Primers were designed with Primer 5.0 software according to primer design principles. Amplify part of the intermediate sequence of the gene. After the sequence was verified to be correct, gene-specific primers GSP1, NGSP1, GSP2, and NGSP2 were designed according to this sequence. The primer sequences of the genes are shown in Table 1, SEQ NOs: 7-10. 5' and 3' RACE amplification was then performed according to the RACE kit. The amplified product was detected by 1% agarose gel electrophoresis, recovered and connected to the PMD19-T Simple vector, transformed, screened for positive clones and sent to BGI for sequencing, and the cDNA sequence was obtained after analysis and splicing, such as SEQ NO: 6, 5 The sequencing result of the 'end sequence is as SEQ NO: 4, and the sequencing result of the 3' end sequence is SEQ NO: 5. The results are shown in Figures 1A-1D. The corresponding gene number in the silkworm genome database is BGIBMGA004577-TA, located on chromosome 27, its scaffold is nscaf2800, and its position is from 531837 to 541893. The full-length cDNA sequence of this gene is 2047bp, and contains a complete open 1821bp long. The reading frame (ORF) encodes a total of 606 amino acid residues, the lengths of the 5' and 3' untranslated regions (UTR) are 399 bp and 693 bp, respectively, and the 3'-UTR structural region contains a tailed signal sequence AATAAA .
表1引物序列Table 1 Primer sequences
实施例3 原核表达载体构建及诱导表达Example 3 Construction of prokaryotic expression vector and induced expression
设计相应带有HindIII和XhoI酶切位点的引物进行PCR扩增,引物序列见表1,如SEQ NO11-16所示。以家蚕四龄眠血液cDNA为模板进行PCR扩增,PCR扩增反应条件为:94℃预变性2分钟,然后94℃变性30秒、55℃退火30秒、72℃延伸1分钟,共25个循环,最后72℃延伸10分钟;PCR产物经琼脂糖凝胶电泳鉴定并回收,回收产物用HindIII和XhoI双酶切,回收BmSRC基因片段,如图2A。PCR产物克隆到原核表达载体pET32a中,命名为pET32a-SRC,如图2B。挑取阳性克隆质粒,转化Rosetta菌株感受态,挑取单菌落接种于含氨苄青霉素的LB培养基中培养12h后,分别转接100μL于两份10mL的LB培养基中。当培养至OD值为0.6-1.0时,加入终浓度为1mmol·L-1的IPTG和2μL·mL-1的氯霉素,分别在16℃、25℃和37℃的条件下300r/min进行培养。其中,16℃组培养20-24h,25℃组培养12-16h,37℃组培养4-6h。将诱导完成后的菌液在5000r/min,4℃条件下离心10min,收集菌体,弃上清,用PBS进行清洗。用1mLPBS重悬菌体后,置于冰上进行超声破碎,直至菌液变得透明。5000r/min,4℃离心10min。分别收集上清和沉淀进行SDS-PAGE电泳。分离胶和浓缩胶浓度分别为10%和5%。考马斯亮蓝染色,脱色,观察结果,结果如图2C。随后,同样挑取单菌落接种于含氨苄青霉素的LB培养基中37℃,280r/min振荡培养至OD值为0.6-1.0时,加入IPTG至终浓度分别为0.2、0.4、0.6mmol·L-1,诱导6h。将诱导完的菌液进行同样的超声破碎、SDS-PAGE电泳和考马斯亮蓝染色,结果如图2D。Design corresponding primers with HindIII and XhoI restriction sites for PCR amplification. The primer sequences are shown in Table 1, as shown in SEQ NOs 11-16. PCR amplification was carried out using the blood cDNA of silkworm fourth instars as a template. The PCR amplification reaction conditions were: 94°C pre-denaturation for 2 minutes, then 94°C denaturation for 30 seconds, 55°C annealing for 30 seconds, and 72°C extension for 1 minute, a total of 25 cycle, and the final extension at 72°C for 10 minutes; the PCR product was identified and recovered by agarose gel electrophoresis, the recovered product was double digested with HindIII and XhoI, and the BmSRC gene fragment was recovered, as shown in Figure 2A. The PCR product was cloned into the prokaryotic expression vector pET32a and named pET32a-SRC, as shown in Figure 2B. The positive cloned plasmids were picked and transformed into competent Rosetta strains. A single colony was picked and inoculated in LB medium containing ampicillin for 12 hours, and then transferred to 100 μL in two 10 mL LB medium respectively. When cultured to an OD value of 0.6-1.0, IPTG with a final concentration of 1 mmol·L-1 and chloramphenicol with a final concentration of 2 μL·mL-1 were added at 300 r/min at 16 °C, 25 °C and 37 °C, respectively. nourish. Among them, the 16°C group was cultured for 20-24 hours, the 25°C group was cultured for 12-16 hours, and the 37°C group was cultured for 4-6 hours. The bacterial solution after induction was centrifuged at 5000 r/min and 4 °C for 10 min, the bacterial cells were collected, the supernatant was discarded, and washed with PBS. After resuspending the bacterial cells in 1 mL of PBS, place them on ice for sonication until the bacterial liquid becomes transparent. Centrifuge at 5000 r/min for 10 min at 4°C. The supernatant and pellet were collected separately for SDS-PAGE electrophoresis. Separating and stacking gel concentrations were 10% and 5%, respectively. Coomassie brilliant blue staining, destaining, observation results, the results are shown in Figure 2C. Subsequently, a single colony was also picked and inoculated into LB medium containing ampicillin at 37°C, shaken at 280 r/min until the OD value was 0.6-1.0, and IPTG was added to the final concentration of 0.2, 0.4, 0.6 mmol·L- 1. Induction for 6h. The induced bacterial solution was subjected to the same ultrasonic disruption, SDS-PAGE electrophoresis and Coomassie brilliant blue staining, and the results were shown in Figure 2D.
实施例4 蛋白纯化Example 4 Protein purification
按照0.2mM IPTG于37℃诱导6h的条件进行大规模诱导表达家蚕C类清道夫受体重组蛋白,图2E为大规模诱导时蛋白的检测,发现诱导成功。然后进行菌体称重,将菌体18g与250mL 50mM Tris-HCL(不调pH,PH高一点好)缓冲液混合(与菌体比例1:10-20),液氮反复冻融三次后溶解,利用匀浆机将其混匀,在摇床中于37℃摇1h后,取出后加入DNA酶(10μg/mL),在匀质过程中,加入250μL 1M MgCl2(终浓度1mM),缓慢加入溶菌酶(0.1mg/ml)后,调节PH至9.5-10左右。放入37℃摇床反应1h左右,搅拌至不黏;取出于-20℃预冷20min后,超声破碎细菌至纯清,高速冷冻离心,分别收集沉淀。用含有5%乙酸、1%Triron以1:20的质量体积比洗涤蛋白包涵体30min,高速冷冻离心,收集沉淀后重复该步骤一次。随后用2M尿素(内含25mM Tris、5mM EDTA)洗涤沉淀一次,高速冷冻离心,收集沉淀。用20mM Tris、0.5MNacl和50%乙醇,pH 7.0洗涤,高速冷冻离心,收集沉淀。用双蒸水洗涤沉淀而去盐,高速冷冻离心,收集沉淀。用8M尿素(内含25Mm Tris-HCl、0.3M NaCL,pH 8.0)溶解包涵体,调pH值至11.5-12.0,搅拌过夜,次日冷冻离心(15000rpm,30min),上清用0.22μm微孔滤膜过滤后备用。最后用Ni+柱(Ni-NTA)纯化重组蛋白(按GE公司提供的操作说明进行),收集洗脱液,利用SDS-PAGE分析洗脱蛋白质的组分,图2F为纯化后得到的包涵体蛋白。Large-scale induction and expression of Bombyx mori C-type scavenger receptor recombinant protein was performed according to the condition of 0.2 mM IPTG induced at 37 °C for 6 h. Figure 2E shows the detection of the protein during large-scale induction, and it was found that the induction was successful. Then weigh the bacterial cells, mix 18 g of the bacterial cells with 250 mL of 50 mM Tris-HCL (without adjusting the pH, a little higher pH is better) buffer (the ratio with the bacterial cells is 1:10-20), and dissolve after repeated freezing and thawing in liquid nitrogen three times. , use a homogenizer to mix it, shake it in a shaker at 37 °C for 1 h, take it out and add DNase (10 μg/mL), during the homogenization process, add 250 μL 1M MgCl2 (final concentration 1mM), slowly add After lysozyme (0.1 mg/ml), adjust the pH to about 9.5-10. Put it into a 37°C shaker for about 1 hour, and stir until it is not sticky; take it out and pre-cool at -20°C for 20 minutes, sonicate the bacteria to pure clearness, freeze and centrifuge at high speed, and collect the precipitates separately. The protein inclusion bodies were washed with 5% acetic acid and 1% Triron at a mass-to-volume ratio of 1:20 for 30 min, followed by high-speed freezing and centrifugation, and the procedure was repeated once after collecting the precipitate. The pellet was then washed once with 2M urea (containing 25mM Tris, 5mM EDTA), refrigerated and centrifuged at high speed to collect the pellet. The pellet was collected by washing with 20 mM Tris, 0.5 M NaCl and 50% ethanol, pH 7.0, high-speed refrigerated centrifugation. The precipitate was washed with double distilled water to remove salt, and the precipitate was collected by high-speed refrigerated centrifugation. Dissolve the inclusion bodies with 8M urea (containing 25Mm Tris-HCl, 0.3M NaCl, pH 8.0), adjust the pH to 11.5-12.0, stir overnight, freeze and centrifuge (15000rpm, 30min) the next day, and use 0.22μm micropores for the supernatant. After filtration through the filter membrane, it is ready for use. Finally, the recombinant protein was purified with Ni + column (Ni-NTA) (according to the operating instructions provided by GE), the eluate was collected, and the components of the eluted protein were analyzed by SDS-PAGE. Figure 2F shows the inclusion bodies obtained after purification. protein.
实施例5 抗血清制备Example 5 Antiserum preparation
使用纯化后的重组蛋白注射健康的成年雄性昆明小鼠3只,每只小鼠注射前剪尾尖取血,收集约50μL正常血清,作为阴性对照,室温静置后离心收集上清,上清与甘油以1∶1的体积比例混合后于–80℃保存。The purified recombinant protein was used to inject 3 healthy adult male Kunming mice. Before the injection, the tail tip of each mouse was cut to take blood, and about 50 μL of normal serum was collected as a negative control. After standing at room temperature, the supernatant was collected by centrifugation. Mixed with glycerol at a volume ratio of 1:1 and stored at –80°C.
小鼠进行免疫时每只腹腔注射5次蛋白,周期为0、10、10、15和21d。第1次与弗式完全佐剂等体积混合,后4次均与弗式不完全佐剂等体积混合。最后1次免疫1周之后,摘除眼球进行取血,室温静置2h,然后3 000r/min离心10min将血清取出,加入30%的甘油后,分装于-80℃中保存。When the mice were immunized, each mouse was intraperitoneally injected with
实施例6 抗家蚕BmSRC蛋白血清的检测Example 6 Detection of anti-Bombyx mori BmSRC protein serum
用家蚕5龄3天各组织(包括中肠、血细胞、生殖腺、脂肪体、马氏管、表皮、头)蛋白为样品,对抗家蚕BmSRC蛋白血清进行Western blot检测,蛋白经SDS-PAGE电泳及转膜后,用含有5%BSA的TBST(Nacl8.8g,1M Tris-HCl(pH8.0)20ml,0.5ml Tween20,定容到1L)于室温封闭2h,将小鼠产生的抗血清以1:5000稀释后于4℃孵育过夜,TBST洗3次,每次10分钟,以1:10000的比例稀释的HRP标记小鼠IgG室温孵育1小时后,再次用TBST洗3次,每次10分钟,用ECL显色液进行显色及用成像仪进行曝光,如图3A所示,小鼠产生的抗血清可以特异的显示5龄3天家蚕各组织中的BmSRC蛋白条带,大小约为60kD。The protein of each tissue (including midgut, blood cells, gonads, fat body, Malpighian duct, epidermis, and head) of silkworm
我们还对家蚕BmSRC蛋白抗血清进行了免疫荧光检测。以家蚕4龄眠的血细胞作为样本,细胞贴壁后,用PBS洗片子3次,每次5分钟后,用含有4%多聚甲醛的PBS室温孵育15分钟,再用PBS洗5分钟,洗3次后,用含有1%BSA和10%山羊血清的PBS封闭液于室温封闭2小时,用封闭液以1:750的比例稀释小鼠产生的抗血清,于4℃孵育过夜后,用PBS洗3次,每次10分钟,再用Alexa488 Donkey Anti-Mouse IgG(H+L)抗体室温孵育1小时,用PBS洗3次,每次10分钟;用PBS以1:2000比例的稀释Hoechst33342室温孵育40分钟后,PBS洗3次,每次10分钟,添加抗荧光淬灭剂然后用指甲油封边后用荧光显微镜成像观察,如图3B所示,BmSRC抗血清可以特异的标记家蚕血液中的BmSRC蛋白,并且标记颗粒细胞和拟浆细胞,并显示其表达于家蚕血液细胞的细胞膜上。We also performed immunofluorescence detection on the antiserum of silkworm BmSRC protein. The blood cells of
综上所述,本发明成功克隆家蚕BmSRC基因,原核表达纯化出有活性的蛋白,通过多次免疫小鼠产生多克隆抗血清,可以进行体内BmSRC蛋白表达水平的western检测,细胞爬片的免疫荧光等实验。这些都为进行家蚕BmSRC蛋白以及鳞翅目昆虫中保守的SRC蛋白的功能研究提供了有利的工具。To sum up, the present invention successfully clones the silkworm BmSRC gene, expresses and purifies the active protein in prokaryotic cells, and produces polyclonal antiserum by immunizing mice multiple times. Fluorescence and other experiments. All these provide useful tools for the functional study of silkworm BmSRC proteins and conserved SRC proteins in lepidopteran insects.
以上所述仅为本发明的较佳实施例,并非用来限定本发明的实施范围;如果不脱离本发明的精神和范围,对本发明进行修改或者等同替换,均应涵盖在本发明权利要求的保护范围当中。The above are only preferred embodiments of the present invention and are not intended to limit the scope of implementation of the present invention; if the present invention is modified or equivalently replaced without departing from the spirit and scope of the present invention, it shall be covered by the claims of the present invention. within the scope of protection.
序列表sequence listing
<110> 西南大学<110> Southwest University
<120> 一种抗家蚕BmSRC多克隆抗血清、制备方法及应用<120> A kind of anti-silkworm BmSRC polyclonal antiserum, preparation method and application
<130> 17P99761-CN<130> 17P99761-CN
<160> 16<160> 16
<170> SIPOSequenceListing 1.0<170> SIPOSequenceListing 1.0
<210> 1<210> 1
<211> 532<211> 532
<212> PRT<212> PRT
<213> Artificial Sequence<213> Artificial Sequence
<400> 1<400> 1
Phe Ala Leu Arg Cys Pro Tyr Pro Tyr Leu Gln His Gly Lys Ala ArgPhe Ala Leu Arg Cys Pro Tyr Pro Tyr Leu Gln His Gly Lys Ala Arg
1 5 10 151 5 10 15
Leu Arg Thr Lys Ser Arg Ile Val Lys Phe Val Cys Asn Pro Arg TyrLeu Arg Thr Lys Ser Arg Ile Val Lys Phe Val Cys Asn Pro Arg Tyr
20 25 30 20 25 30
Lys Leu Val Gly Asn Lys Tyr Ser Ile Cys Arg Met Gly Arg Trp GluLys Leu Val Gly Asn Lys Tyr Ser Ile Cys Arg Met Gly Arg Trp Glu
35 40 45 35 40 45
Glu Gln Leu Pro Val Cys Val Lys Ser Gly Cys Pro Lys Leu Pro ProGlu Gln Leu Pro Val Cys Val Lys Ser Gly Cys Pro Lys Leu Pro Pro
50 55 60 50 55 60
Ile Gln Met Thr His His Asp Gly Ala Trp Leu Met Thr Phe Cys LeuIle Gln Met Thr His His Asp Gly Ala Trp Leu Met Thr Phe Cys Leu
65 70 75 8065 70 75 80
Pro Asn Tyr Arg Leu Glu Gly Ser Glu Val Leu Tyr Cys Asn Gly TyrPro Asn Tyr Arg Leu Glu Gly Ser Glu Val Leu Tyr Cys Asn Gly Tyr
85 90 95 85 90 95
Arg Trp Asn Ser Thr Ala Pro Lys Cys Val Glu Met Asn Asn Asn ValArg Trp Asn Ser Thr Ala Pro Lys Cys Val Glu Met Asn Asn Asn Val
100 105 110 100 105 110
Thr Thr Ile Lys Tyr Ser Cys Asp Phe Glu Glu Asp Leu Cys Gly TrpThr Thr Ile Lys Tyr Ser Cys Asp Phe Glu Glu Asp Leu Cys Gly Trp
115 120 125 115 120 125
Ile Gln Asp Glu Phe His Asp Phe Asp Trp Lys Arg Leu Asn Thr LysIle Gln Asp Glu Phe His Asp Phe Asp Trp Lys Arg Leu Asn Thr Lys
130 135 140 130 135 140
Thr Pro Ser Ser Phe Thr Leu Thr Gly Pro Trp Phe Asp His Thr TyrThr Pro Ser Ser Phe Thr Leu Thr Gly Pro Trp Phe Asp His Thr Tyr
145 150 155 160145 150 155 160
Gly Ser Arg Gly Lys Gly His Phe Met Tyr Ile Glu Ser Thr Gly ArgGly Ser Arg Gly Lys Gly His Phe Met Tyr Ile Glu Ser Thr Gly Arg
165 170 175 165 170 175
Phe Ile Asn Asp Thr Ala Arg Leu Leu Ser Pro Ile Tyr Asp Ser AlaPhe Ile Asn Asp Thr Ala Arg Leu Leu Ser Pro Ile Tyr Asp Ser Ala
180 185 190 180 185 190
Ile Ala Lys Asp Gly Cys Phe Gln Leu Tyr Tyr His Met Tyr Gly ArgIle Ala Lys Asp Gly Cys Phe Gln Leu Tyr Tyr His Met Tyr Gly Arg
195 200 205 195 200 205
Ser Leu Gly Gly Leu Arg Val Tyr Gln Lys Pro Asp Ser Val Asp LeuSer Leu Gly Gly Leu Arg Val Tyr Gln Lys Pro Asp Ser Val Asp Leu
210 215 220 210 215 220
Met Thr Met Leu Ala Ser Glu Glu Gln Arg Lys Asp Tyr Ile Ile PheMet Thr Met Leu Ala Ser Glu Glu Gln Arg Lys Asp Tyr Ile Ile Phe
225 230 235 240225 230 235 240
Glu Lys Trp Gly Glu Gln Gly Asp Leu Trp Leu Ser Ala Ala Pro ArgGlu Lys Trp Gly Glu Gln Gly Asp Leu Trp Leu Ser Ala Ala Pro Arg
245 250 255 245 250 255
Leu Lys Asp Phe Asn Glu Asp Phe Gln Ile Val Ile Glu Gly Ile ArgLeu Lys Asp Phe Asn Glu Asp Phe Gln Ile Val Ile Glu Gly Ile Arg
260 265 270 260 265 270
Gly Ser Ser Phe Met Ser Asp Leu Ala Ile Asp Asp Ile Ser Val LeuGly Ser Ser Phe Met Ser Asp Leu Ala Ile Asp Asp Ile Ser Val Leu
275 280 285 275 280 285
Arg Gly Gln Lys Cys Val Asp Ala Ala Ala His Ala Ile Thr Pro SerArg Gly Gln Lys Cys Val Asp Ala Ala Ala His Ala Ile Thr Pro Ser
290 295 300 290 295 300
Pro Tyr Lys Ala Asp Ser Cys Val Gly Arg Cys Phe Gln Asn Ile ThrPro Tyr Lys Ala Asp Ser Cys Val Gly Arg Cys Phe Gln Asn Ile Thr
305 310 315 320305 310 315 320
Ile Thr Arg Gly Cys Gly Cys Asp Gly Asp Cys Val Ile Tyr Gly TyrIle Thr Arg Gly Cys Gly Cys Asp Gly Asp Cys Val Ile Tyr Gly Tyr
325 330 335 325 330 335
Cys Cys Gln Asp Phe Val Asp Leu Cys Ile Glu Lys Asp Pro Glu ThrCys Cys Gln Asp Phe Val Asp Leu Cys Ile Glu Lys Asp Pro Glu Thr
340 345 350 340 345 350
Thr Val Ile Ala Glu Thr Gly Ser Thr Val Ala Leu Pro Gln Thr GlnThr Val Ile Ala Glu Thr Gly Ser Thr Val Ala Leu Pro Gln Thr Gln
355 360 365 355 360 365
Lys Leu Val Ala Ser Thr Thr Asn Ala Thr Thr Ser Thr Ser Thr ThrLys Leu Val Ala Ser Thr Thr Asn Ala Thr Thr Ser Thr Ser Thr Thr
370 375 380 370 375 380
Thr Thr Thr Thr Pro Lys Pro Ile Val Ile Leu Ser Thr Lys Thr ThrThr Thr Thr Thr Pro Lys Pro Ile Val Ile Leu Ser Thr Lys Thr Thr
385 390 395 400385 390 395 400
Thr Thr Thr Ala Ser Pro Lys Pro Thr Thr Pro Thr Thr Thr Ser ThrThr Thr Thr Ala Ser Pro Lys Pro Thr Thr Pro Thr Thr Thr Ser Thr
405 410 415 405 410 415
Lys Thr Phe Pro Thr Ile Pro Thr Arg Thr Thr Thr Ile Thr Val SerLys Thr Phe Pro Thr Ile Pro Thr Arg Thr Thr Thr Ile Thr Val Ser
420 425 430 420 425 430
Lys Thr Pro Lys Thr Ser Thr Lys Thr Thr Ile Ala Arg Arg Ser SerLys Thr Pro Lys Thr Ser Thr Lys Thr Thr Ile Ala Arg Arg Ser Ser
435 440 445 435 440 445
Ser Pro Ser Gln Lys Gln Thr Thr Lys Val Leu Lys Pro Thr Thr GlnSer Pro Ser Gln Lys Gln Thr Thr Lys Val Leu Lys Pro Thr Thr Gln
450 455 460 450 455 460
Ser Ser Ser Ile Thr Pro Lys Ser Ala Thr Arg Lys Val Thr Ser ValSer Ser Ser Ile Thr Pro Lys Ser Ala Thr Arg Lys Val Thr Ser Val
465 470 475 480465 470 475 480
Ala Ser Thr Thr Val Gly Ser Lys Lys Leu Thr Ser Ser Thr Thr ValAla Ser Thr Thr Val Gly Ser Lys Lys Leu Thr Ser Ser Thr Thr Val
485 490 495 485 490 495
Lys Pro Ala Ser Thr Ser Lys Lys Val Thr Glu Lys Gln Ser Phe ThrLys Pro Ala Ser Thr Ser Lys Lys Val Thr Glu Lys Gln Ser Phe Thr
500 505 510 500 505 510
Lys Lys Met Thr Val Asp Val Phe Val Ala Lys Lys Ser Lys Gly AlaLys Lys Met Thr Val Asp Val Phe Val Ala Lys Lys Ser Lys Gly Ala
515 520 525 515 520 525
Ser Lys Thr LeuSer Lys Thr Leu
530 530
<210> 2<210> 2
<211> 1596<211> 1596
<212> DNA<212> DNA
<213> Artificial Sequence<213> Artificial Sequence
<400> 2<400> 2
ttcgctctaa gatgtcctta cccatatcta cagcatggca aagctagatt gcgaactaag 60ttcgctctaa gatgtcctta cccatatcta cagcatggca aagctagatt gcgaactaag 60
tccagaatcg tgaagttcgt atgtaaccct agatataaat tggttgggaa caaatactct 120tccagaatcg tgaagttcgt atgtaaccct agatataaat tggttgggaa caaatactct 120
atatgtcgaa tggggcgttg ggaggagcag ctgccggtct gtgttaaatc aggctgccct 180atatgtcgaa tggggcgttg ggaggagcag ctgccggtct gtgttaaatc aggctgccct 180
aaattgccac caattcagat gacgcatcac gatggcgctt ggctcatgac gttctgcctc 240aaattgccac caattcagat gacgcatcac gatggcgctt ggctcatgac gttctgcctc 240
ccgaactaca gattagaggg ttcagaagtg ttatactgca acggatacag atggaatagc 300ccgaactaca gattagaggg ttcagaagtg ttatactgca acggatacag atggaatagc 300
actgcgccta aatgcgttga gatgaacaac aacgtaacaa cgatcaagta cagttgcgac 360actgcgccta aatgcgttga gatgaacaac aacgtaacaa cgatcaagta cagttgcgac 360
ttcgaagagg acctctgcgg ttggatacag gacgagttcc acgatttcga ttggaagcga 420ttcgaagagg acctctgcgg ttggatacag gacgagttcc acgatttcga ttggaagcga 420
ctgaacacga aaactccgag ctcctttacg cttaccggac cgtggtttga tcacacgtac 480ctgaacacga aaactccgag ctcctttacg cttaccggac cgtggtttga tcacacgtac 480
ggctccagag gaaagggcca tttcatgtat atcgagagta ctgggcgttt cattaacgat 540ggctccagag gaaagggcca tttcatgtat atcgagagta ctgggcgttt cattaacgat 540
acagcccgac ttttatcgcc gatttacgat tcggccatag cgaaggacgg atgttttcag 600acagcccgac ttttatcgcc gatttacgat tcggccatag cgaaggacgg atgttttcag 600
ctttattatc acatgtatgg aagatcatta ggaggcctta gggtatacca aaaaccggac 660ctttattatc acatgtatgg aagatcatta ggaggcctta gggtatacca aaaaccggac 660
agcgtcgatt taatgacgat gctggcttca gaggaacagc gaaaggatta cattattttt 720agcgtcgatt taatgacgat gctggcttca gaggaacagc gaaaggatta cattattttt 720
gaaaagtggg gcgaacaagg tgacctctgg ctttccgctg ctccacgact aaaggacttt 780gaaaagtggg gcgaacaagg tgacctctgg ctttccgctg ctccacgact aaaggacttt 780
aacgaagact ttcagatagt gatcgaagga atccgaggat ccagtttcat gagcgacctg 840aacgaagact ttcagatagt gatcgaagga atccgaggat ccagtttcat gagcgacctg 840
gctattgacg atatttccgt gttgagagga cagaagtgcg tagacgcagc ggcgcatgca 900gctattgacg atatttccgt gttgagagga cagaagtgcg tagacgcagc ggcgcatgca 900
atcaccccct ctccttataa agccgactct tgcgtcggtc gatgcttcca aaatataact 960atcaccccct ctccttataa agccgactct tgcgtcggtc gatgcttcca aaatataact 960
atcacaagag gctgtggttg cgacggagac tgcgtcatct atggctactg ctgtcaagac 1020atcacaagag gctgtggttg cgacggagac tgcgtcatct atggctactg ctgtcaagac 1020
ttcgtagatc tatgcatcga aaaagatccc gaaacaacag tgattgccga aactggttcg 1080ttcgtagatc tatgcatcga aaaagatccc gaaacaacag tgattgccga aactggttcg 1080
accgttgcat taccgcaaac acagaaacta gtagcttcta caaccaacgc tacaacttca 1140accgttgcat taccgcaaac acagaaacta gtagcttcta caaccaacgc tacaacttca 1140
acttcaacca caacgacgac tacacccaaa cccattgtta tactttcaac taaaactacc 1200acttcaacca caacgacgac tacacccaaa cccattgtta tactttcaac taaaactacc 1200
actactactg cttctcccaa acctacgact cccactacca ccagtactaa gacttttcct 1260actactactg cttctcccaa acctacgact cccactacca ccagtactaa gacttttcct 1260
actattccca caaggaccac tactatcaca gtcagtaaaa ctccaaaaac cagtaccaaa 1320actattccca caaggaccac tactatcaca gtcagtaaaa ctccaaaaac cagtaccaaa 1320
acgaccatag ccagacgttc ctctagccca tcccagaaac agaccaccaa ggtccttaag 1380acgaccatag ccagacgttc ctctagccca tcccagaaac agaccaccaa ggtccttaag 1380
cctacgactc agtccagttc catcacacct aagagtgcaa ctcgtaaggt gacgtctgtc 1440cctacgactc agtccagttc catcacacct aagagtgcaa ctcgtaaggt gacgtctgtc 1440
gcttcgacca cagttgggag taaaaaatta acatccagca ctacagtaaa acctgctagt 1500gcttcgacca cagttgggag taaaaaatta acatccagca ctacagtaaa acctgctagt 1500
accagcaaaa aggttactga aaaacagtct tttaccaaga agatgacggt ggacgttttt 1560accagcaaaa aggttactga aaaacagtct tttaccaaga agatgacggt ggacgttttt 1560
gttgcgaaga aatcgaaagg agcctcaaaa acactg 1596gttgcgaaga aatcgaaagg agcctcaaaa acactg 1596
<210> 3<210> 3
<211> 1563<211> 1563
<212> DNA<212> DNA
<213> Artificial Sequence<213> Artificial Sequence
<400> 3<400> 3
atgacgcatc acgatggcgc ttggctcatg acgttctgcc tcccgaacta cagattagag 60atgacgcatc acgatggcgc ttggctcatg acgttctgcc tcccgaacta cagattagag 60
ggttcagaag tgttatactg caacggatac agatggaata gcactgcgcc taaatgcgtt 120ggttcagaag tgttatactg caacggatac agatggaata gcactgcgcc taaatgcgtt 120
gagatgaaca acaacgtaac aacgatcaag tacagttgcg acttcgaaga ggacctctgc 180gagatgaaca acaacgtaac aacgatcaag tacagttgcg acttcgaaga ggacctctgc 180
ggttggatac aggacgagtt ccacgatttc gattggaagc gactgaacac gaaaactccg 240ggttggatac aggacgagtt ccacgatttc gattggaagc gactgaacac gaaaactccg 240
agctccttta cgcttaccgg accgtggttt gatcacacgt acggctccag aggaaagggc 300agctccttta cgcttaccgg accgtggttt gatcacacgt acggctccag aggaaagggc 300
catttcatgt atatcgagag tactgggcgt ttcattaacg atacagcccg acttttatcg 360catttcatgt atatcgagag tactgggcgt ttcattaacg atacagcccg acttttatcg 360
ccgatttacg attcggccat agcgaaggac ggatgttttc agctttatta tcacatgtat 420ccgatttacg attcggccat agcgaaggac ggatgttttc agctttatta tcacatgtat 420
ggaagatcat taggaggcct tagggtatac caaaaaccgg acagcgtcga tttaatgacg 480ggaagatcat taggaggcct tagggtatac caaaaaccgg acagcgtcga tttaatgacg 480
atgctggctt cagaggaaca gcgaaaggat tacattattt ttgaaaagtg gggcgaacaa 540atgctggctt cagaggaaca gcgaaaggat tacattattt ttgaaaagtg gggcgaacaa 540
ggtgacctct ggctttccgc tgctccacga ctaaaggact ttaacgaaga ctttcagata 600ggtgacctct ggctttccgc tgctccacga ctaaaggact ttaacgaaga ctttcagata 600
gtgatcgaag gaatccgagg atccagtttc atgagcgacc tggctattga cgatatttcc 660gtgatcgaag gaatccgagg atccagtttc atgagcgacc tggctattga cgatatttcc 660
gtgttgagag gacagaagtg cgtagacgca gcggcgcatg caatcacccc ctctccttat 720gtgttgagag gacagaagtg cgtagacgca gcggcgcatg caatcacccc ctctccttat 720
aaagccgact cttgcgtcgg tcgatgcttc caaaatataa ctatcacaag aggctgtggt 780aaagccgact cttgcgtcgg tcgatgcttc caaaatataa ctatcacaag aggctgtggt 780
tgcgacggag actgcgtcat ctatggctac tgctgtcaag acttcgtaga tctatgcatc 840tgcgacggag actgcgtcat ctatggctac tgctgtcaag acttcgtaga tctatgcatc 840
gaaaaagatc ccgaaacaac agtgattgcc gaaactggtt cgaccgttgc attaccgcaa 900gaaaaagatc ccgaaacaac agtgattgcc gaaactggtt cgaccgttgc attaccgcaa 900
acacagaaac tagtagcttc tacaaccaac gctacaactt caacttcaac cacaacgacg 960acacagaaac tagtagcttc tacaaccaac gctacaactt caacttcaac cacaacgacg 960
actacaccca aacccattgt tatactttca actaaaacta ccactactac tgcttctccc 1020actacaccca aacccattgt tatactttca actaaaacta ccactactac tgcttctccc 1020
aaacctacga ctcccactac caccagtact aagacttttc ctactattcc cacaaggacc 1080aaacctacga ctcccactac caccagtact aagacttttc ctactattcc cacaaggacc 1080
actactatca cagtcagtaa aactccaaaa accagtacca aaacgaccat agccagacgt 1140actactatca cagtcagtaa aactccaaaa accagtacca aaacgaccat agccagacgt 1140
tcctctagcc catcccagaa acagaccacc aaggtcctta agcctacgac tcagtccagt 1200tcctctagcc catcccagaa acagaccacc aaggtcctta agcctacgac tcagtccagt 1200
tccatcacac ctaagagtgc aactcgtaag gtgacgtctg tcgcttcgac cacagttggg 1260tccatcacac ctaagagtgc aactcgtaag gtgacgtctg tcgcttcgac cacagttggg 1260
agtaaaaaat taacatccag cactacagta aaacctgcta gtaccagcaa aaaggttact 1320agtaaaaaat taacatccag cactacagta aaacctgcta gtaccagcaa aaaggttact 1320
gaaaaacagt cttttaccaa gaagatgacg gtggacgttt ttgttgcgaa gaaatcgaaa 1380gaaaaacagt cttttaccaa gaagatgacg gtggacgttt ttgttgcgaa gaaatcgaaa 1380
ggagcctcaa aaacactgca aacgtctggc ataatagttg gtgtgttgtt ttgtgtattt 1440ggagcctcaa aaacactgca aacgtctggc ataatagttg gtgtgttgtt ttgtgtattt 1440
gcgttggtcg gatccgtggt ggcttggcga cgttacggcg gcatgatgat cgttagaagg 1500gcgttggtcg gatccgtggt ggcttggcga cgttacggcg gcatgatgat cgttagaagg 1500
ttgagaggtc aaatcgcgaa tgaccctgaa gtgcgctatc tgagtgccca tatggacgat 1560ttgagaggtc aaatcgcgaa tgaccctgaa gtgcgctatc tgagtgccca tatggacgat 1560
tga 1563tga 1563
<210> 4<210> 4
<211> 399<211> 399
<212> DNA<212> DNA
<213> Artificial Sequence<213> Artificial Sequence
<400> 4<400> 4
ggacactgac atggactgaa ggagtagaaa atttttgaaa atgttctgac accgcgaata 60ggacactgac atggactgaa ggagtagaaa atttttgaaa atgttctgac accgcgaata 60
gttaagtcta aattcggaaa tgacatgaac ggattaaatt atataaaaaa ataattttga 120gttaagtcta aattcggaaa tgacatgaac ggattaaatt atataaaaaa ataattttga 120
acaaaacttt aaaaaaaaga agtgaaacat gaatttatta tataagtgta ttttatcgtt 180acaaaacttt aaaaaaaaga agtgaaacat gaatttatta tataagtgta ttttatcgtt 180
aatgtttttt tgttatatcg aggcccaatt cgctctaaga tgtccttacc catatctaca 240aatgtttttt tgttatatcg aggcccaatt cgctctaaga tgtccttacc catatctaca 240
gcatggcaaa gctagattgc gaactaagtc cagaatcgtg aagttcgtat gtaaccctag 300gcatggcaaa gctagattgc gaactaagtc cagaatcgtg aagttcgtat gtaaccctag 300
atataaattg gttgggaaca aatactctat atgtcgaatg gggcgttggg aggagcagct 360atataaattg gttgggaaca aatactctat atgtcgaatg gggcgttggg aggagcagct 360
gccggtctgt gttaaatcag gctgccctaa attgccacc 399gccggtctgt gttaaatcag gctgccctaa attgccacc 399
<210> 5<210> 5
<211> 700<211> 700
<212> DNA<212> DNA
<213> Artificial Sequence<213> Artificial Sequence
<400> 5<400> 5
accacaacga cgactacacc caaacccatt gttatacttt caactaaaac taccactact 60accacaacga cgactacacc caaacccatt gttatacttt caactaaaac taccactact 60
actgcttctc ccaaacctac gactcccact accaccagta ctaagacttt tcctactatt 120actgcttctc ccaaacctac gactcccact accaccagta ctaagacttt tcctactatt 120
cccacaagga ccactactat cacagtcagt aaaactccaa aaaccagtac caaaacgacc 180cccacaagga ccactactat cacagtcagt aaaactccaa aaaccagtac caaaacgacc 180
atagccagac gttcctctag cccatcccag aaacagacca ccaaggtcct taagcctacg 240atagccagac gttcctctag cccatcccag aaacagacca ccaaggtcct taagcctacg 240
actcagtcca gttccatcac acctaagagt gcaactcgta aggtgacgtc tgtcgcttcg 300actcagtcca gttccatcac acctaagagt gcaactcgta aggtgacgtc tgtcgcttcg 300
accacagttg ggagtaaaaa attaacatcc agcactacag taaaacctgc tagtaccagc 360accacagttg ggagtaaaaa attaacatcc agcactacag taaaacctgc tagtaccagc 360
aaaaaggtta ctgaaaaaca gtcttttacc aagaagatga cggtggacgt ttttgttgcg 420aaaaaggtta ctgaaaaaca gtcttttacc aagaagatga cggtggacgt ttttgttgcg 420
aagaaatcga aaggagcctc aaaaacactg caaacgtctg gcataatagt tggtgtgttg 480aagaaatcga aaggagcctc aaaaacactg caaacgtctg gcataatagt tggtgtgttg 480
ttttgtgtat ttgcgttggt cggatccgtg gtggcttggc gacgttacgg cggcatgatg 540ttttgtgtat ttgcgttggt cggatccgtg gtggcttggc gacgttacgg cggcatgatg 540
atcgttagaa ggttgagagg tcaaatcgcg aatgaccctg aagtgcgcta tctgagtgcc 600atcgttagaa ggttgagagg tcaaatcgcg aatgaccctg aagtgcgcta tctgagtgcc 600
catatggacg attgaactgt tcttttaaaa taaactattt tagctttaaa aaaaaggaag 660catatggacg attgaactgt tcttttaaaa taaactattt tagctttaaa aaaaaggaag 660
aaaaaaatag taataaccac tgtcatgccg ttacgtagcg 700aaaaaaatag taataaccac tgtcatgccg ttacgtagcg 700
<210> 6<210> 6
<211> 2047<211> 2047
<212> DNA<212> DNA
<213> Artificial Sequence<213> Artificial Sequence
<400> 6<400> 6
ggacactgac atggactgaa ggagtagaaa atttttgaaa atgttctgac accgcgaata 60ggacactgac atggactgaa ggagtagaaa atttttgaaa atgttctgac accgcgaata 60
gttaagtcta aattcggaaa tgacatgaac ggattaaatt atataaaaaa ataattttga 120gttaagtcta aattcggaaa tgacatgaac ggattaaatt atataaaaaa ataattttga 120
acaaaacttt aaaaaaaaga agtgaaacat gaatttatta tataagtgta ttttatcgtt 180acaaaacttt aaaaaaaaga agtgaaacat gaatttatta tataagtgta ttttatcgtt 180
aatgtttttt tgttatatcg aggcccaatt cgctctaaga tgtccttacc catatctaca 240aatgtttttt tgttatatcg aggcccaatt cgctctaaga tgtccttacc catatctaca 240
gcatggcaaa gctagattgc gaactaagtc cagaatcgtg aagttcgtat gtaaccctag 300gcatggcaaa gctagattgc gaactaagtc cagaatcgtg aagttcgtat gtaaccctag 300
atataaattg gttgggaaca aatactctat atgtcgaatg gggcgttggg aggagcagct 360atataaattg gttgggaaca aatactctat atgtcgaatg gggcgttggg aggagcagct 360
gccggtctgt gttaaatcag gctgccctaa attgccacca attcagatga cgcatcacga 420gccggtctgt gttaaatcag gctgccctaa attgccacca attcagatga cgcatcacga 420
tggcgcttgg ctcatgacgt tctgcctccc gaactacaga ttagagggtt cagaagtgtt 480tggcgcttgg ctcatgacgt tctgcctccc gaactacaga ttagagggtt cagaagtgtt 480
atactgcaac ggatacagat ggaatagcac tgcgcctaaa tgcgttgaga tgaacaacaa 540atactgcaac ggatacagat ggaatagcac tgcgcctaaa tgcgttgaga tgaacaacaa 540
cgtaacaacg atcaagtaca gttgcgactt cgaagaggac ctctgcggtt ggatacagga 600cgtaacaacg atcaagtaca gttgcgactt cgaagaggac ctctgcggtt ggatacagga 600
cgagttccac gatttcgatt ggaagcgact gaacacgaaa actccgagct cctttacgct 660cgagttccac gatttcgatt ggaagcgact gaacacgaaa actccgagct cctttacgct 660
taccggaccg tggtttgatc acacgtacgg ctccagagga aagggccatt tcatgtatat 720taccggaccg tggtttgatc acacgtacgg ctccagagga aagggccatt tcatgtatat 720
cgagagtact gggcgtttca ttaacgatac agcccgactt ttatcgccga tttacgattc 780cgagagtact gggcgtttca ttaacgatac agcccgactt ttatcgccga tttacgattc 780
ggccatagcg aaggacggat gttttcagct ttattatcac atgtatggaa gatcattagg 840ggccatagcg aaggacggat gttttcagct ttattatcac atgtatggaa gatcattagg 840
aggccttagg gtataccaaa aaccggacag cgtcgattta atgacgatgc tggcttcaga 900aggccttagg gtataccaaa aaccggacag cgtcgattta atgacgatgc tggcttcaga 900
ggaacagcga aaggattaca ttatttttga aaagtggggc gaacaaggtg acctctggct 960ggaacagcga aaggattaca ttatttttga aaagtggggc gaacaaggtg acctctggct 960
ttccgctgct ccacgactaa aggactttaa cgaagacttt cagatagtga tcgaaggaat 1020ttccgctgct ccacgactaa aggactttaa cgaagacttt cagatagtga tcgaaggaat 1020
ccgaggatcc agtttcatga gcgacctggc tattgacgat atttccgtgt tgagaggaca 1080ccgaggatcc agtttcatga gcgacctggc tattgacgat atttccgtgt tgagaggaca 1080
gaagtgcgta gacgcagcgg cgcatgcaat caccccctct ccttataaag ccgactcttg 1140gaagtgcgta gacgcagcgg cgcatgcaat caccccctct ccttataaag ccgactcttg 1140
cgtcggtcga tgcttccaaa atataactat cacaagaggc tgtggttgcg acggagactg 1200cgtcggtcga tgcttccaaa atataactat cacaagaggc tgtggttgcg acggagactg 1200
cgtcatctat ggctactgct gtcaagactt cgtagatcta tgcatcgaaa aagatcccga 1260cgtcatctat ggctactgct gtcaagactt cgtagatcta tgcatcgaaa aagatcccga 1260
aacaacagtg attgccgaaa ctggttcgac cgttgcatta ccgcaaacac agaaactagt 1320aacaacagtg attgccgaaa ctggttcgac cgttgcatta ccgcaaacac agaaactagt 1320
agcttctaca accaacgcta caacttcaac ttcaaccaca acgacgacta cacccaaacc 1380agcttctaca accaacgcta caacttcaac ttcaaccaca acgacgacta cacccaaacc 1380
cattgttata ctttcaacta aaactaccac tactactgct tctcccaaac ctacgactcc 1440cattgttata ctttcaacta aaactaccac tactactgct tctcccaaac ctacgactcc 1440
cactaccacc agtactaaga cttttcctac tattcccaca aggaccacta ctatcacagt 1500cactaccacc agtactaaga cttttcctac tattcccaca aggaccacta ctatcacagt 1500
cagtaaaact ccaaaaacca gtaccaaaac gaccatagcc agacgttcct ctagcccatc 1560cagtaaaact ccaaaaacca gtaccaaaac gaccatagcc agacgttcct ctagcccatc 1560
ccagaaacag accaccaagg tccttaagcc tacgactcag tccagttcca tcacacctaa 1620ccagaaacag accaccaagg tccttaagcc tacgactcag tccagttcca tcacacctaa 1620
gagtgcaact cgtaaggtga cgtctgtcgc ttcgaccaca gttgggagta aaaaattaac 1680gagtgcaact cgtaaggtga cgtctgtcgc ttcgaccaca gttgggagta aaaaattaac 1680
atccagcact acagtaaaac ctgctagtac cagcaaaaag gttactgaaa aacagtcttt 1740atccagcact acagtaaaac ctgctagtac cagcaaaaag gttactgaaa aacagtcttt 1740
taccaagaag atgacggtgg acgtttttgt tgcgaagaaa tcgaaaggag cctcaaaaac 1800taccaagaag atgacggtgg acgtttttgt tgcgaagaaa tcgaaaggag cctcaaaaac 1800
actgcaaacg tctggcataa tagttggtgt gttgttttgt gtatttgcgt tggtcggatc 1860actgcaaacg tctggcataa tagttggtgt gttgttttgt gtatttgcgt tggtcggatc 1860
cgtggtggct tggcgacgtt acggcggcat gatgatcgtt agaaggttga gaggtcaaat 1920cgtggtggct tggcgacgtt acggcggcat gatgatcgtt agaaggttga gaggtcaaat 1920
cgcgaatgac cctgaagtgc gctatctgag tgcccatatg gacgattgaa ctgttctttt 1980cgcgaatgac cctgaagtgc gctatctgag tgcccatatg gacgattgaa ctgttctttt 1980
aaaataaact attttagcta gaaaaaaaaa aaaaaaaaaa aaaacactgt catgccgtta 2040aaaataaact attttagcta gaaaaaaaaa aaaaaaaaaa aaaacactgt catgccgtta 2040
cgtagcg 2047cgtagcg 2047
<210> 7<210> 7
<211> 24<211> 24
<212> DNA<212> DNA
<213> Artificial Sequence<213> Artificial Sequence
<400> 7<400> 7
ggagccgtac gtgtgatcaa acca 24ggagccgtac gtgtgatcaa acca 24
<210> 8<210> 8
<211> 26<211> 26
<212> DNA<212> DNA
<213> Artificial Sequence<213> Artificial Sequence
<400> 8<400> 8
ggtggcaatt tagggcagcc tgattt 26ggtggcaatt tagggcagcc tgatt 26
<210> 9<210> 9
<211> 24<211> 24
<212> DNA<212> DNA
<213> Artificial Sequence<213> Artificial Sequence
<400> 9<400> 9
cgactcttgc gtcggtcgat gctt 24cgactcttgc gtcggtcgat gctt 24
<210> 10<210> 10
<211> 24<211> 24
<212> DNA<212> DNA
<213> Artificial Sequence<213> Artificial Sequence
<400> 10<400> 10
accacaacga cgactacacc caaa 24accacaacga cgactacacc caaa 24
<210> 11<210> 11
<211> 19<211> 19
<212> DNA<212> DNA
<213> Artificial Sequence<213> Artificial Sequence
<400> 11<400> 11
accgtgccag gctgtacta 19accgtgccag gctgtacta 19
<210> 12<210> 12
<211> 17<211> 17
<212> DNA<212> DNA
<213> Artificial Sequence<213> Artificial Sequence
<400> 12<400> 12
atttctgcgg gcgtttt 17atttctgcgg gcgtttt 17
<210> 13<210> 13
<211> 25<211> 25
<212> DNA<212> DNA
<213> Artificial Sequence<213> Artificial Sequence
<400> 13<400> 13
atgaatttat tatataagtg tattt 25atgaatttat tatataagtg tattt 25
<210> 14<210> 14
<211> 17<211> 17
<212> DNA<212> DNA
<213> Artificial Sequence<213> Artificial Sequence
<400> 14<400> 14
atcgtccata tgggcac 17atcgtccata tgggcac 17
<210> 15<210> 15
<211> 22<211> 22
<212> DNA<212> DNA
<213> Artificial Sequence<213> Artificial Sequence
<400> 15<400> 15
ttcgctctaa gatgtcctta cc 22ttcgctctaa gatgtcctta cc 22
<210> 16<210> 16
<211> 18<211> 18
<212> DNA<212> DNA
<213> Artificial Sequence<213> Artificial Sequence
<400> 16<400> 16
cagtgttttt gaggctcc 18cagtgttttt gaggctcc 18
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201711468725.3A CN108178797B (en) | 2017-12-29 | 2017-12-29 | A kind of anti-silkworm BmSRC polyclonal antiserum, preparation method and application |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201711468725.3A CN108178797B (en) | 2017-12-29 | 2017-12-29 | A kind of anti-silkworm BmSRC polyclonal antiserum, preparation method and application |
Publications (2)
Publication Number | Publication Date |
---|---|
CN108178797A CN108178797A (en) | 2018-06-19 |
CN108178797B true CN108178797B (en) | 2020-12-01 |
Family
ID=62548696
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201711468725.3A Active CN108178797B (en) | 2017-12-29 | 2017-12-29 | A kind of anti-silkworm BmSRC polyclonal antiserum, preparation method and application |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN108178797B (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111454356A (en) * | 2020-05-06 | 2020-07-28 | 南通大学 | A kind of Cabs1 protein antibody and preparation method and application thereof |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA1340977C (en) * | 1988-11-15 | 2000-04-25 | Monty Krieger | Scavenger receptor protein and antibody thereto |
US6703491B1 (en) * | 1999-03-17 | 2004-03-09 | Exelixis, Inc. | Drosophila sequences |
JP2003530869A (en) * | 2000-04-27 | 2003-10-21 | スミスクライン・ビーチャム・コーポレイション | New compound |
US8524233B2 (en) * | 2008-03-14 | 2013-09-03 | Biocon Limited & Centro de Immunologia Molecular | Monoclonal antibody and a method thereof |
-
2017
- 2017-12-29 CN CN201711468725.3A patent/CN108178797B/en active Active
Non-Patent Citations (3)
Title |
---|
scavenger receptor type C precursor [Bombyx mori];GenBank;《GenBank》;20170625;NP_001128387.1 * |
TmSR-C, scavenger receptor class C, plays a pivotal role in antifungal and antibacterial immunity in the coleopteran insect Tenebrio molitor;Soo Gon Kim 等;《Insect Biochemistry and Molecular Biology》;20170901;第89卷;第31-42页 * |
家蚕 B 类清道夫受体 BmSCRB8 基因的克隆及表达;赵羽卒 等;《生物工程学报》;20161025;第32卷(第10期);摘要、第1409-1417页 * |
Also Published As
Publication number | Publication date |
---|---|
CN108178797A (en) | 2018-06-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US10889624B2 (en) | Proteins from the webs of nephilengys cruentata, a vicularia juruensis and parawixia bistriata spiders isolated from brazilian biodiversity | |
JP2003511071A (en) | Cell penetrating peptide inhibitor of JNK signal transduction pathway | |
Helm et al. | Expression and native structure of cytosolic class II small heat-shock proteins | |
KR20220106981A (en) | Recombinant CDKL5 protein, gene therapy and production methods | |
CN108178797B (en) | A kind of anti-silkworm BmSRC polyclonal antiserum, preparation method and application | |
Zeng et al. | Identification and molecular characterization of three new K+-channel specific toxins from the Chinese scorpion Mesobuthus martensii Karsch revealing intronic number polymorphism and alternative splicing in duplicated genes | |
CN111333709A (en) | B cell epitope polypeptide of trichina muscle larva serine protease inhibitor, hybridoma cell strain, monoclonal antibody and application | |
JP2000509022A (en) | Cyclic peptide vaccine for the treatment and prevention of diabetes | |
CN105273072B (en) | Anticoagulant protein B26 of tick and its gene and application | |
CN107365372B (en) | An L-type lectin of Litopenaeus vannamei and its encoding gene and application | |
Zhang et al. | Molecular characterization, tissue distribution, subcellular localization and actin-sequestering function of a thymosin protein from silkworm | |
CN111303276A (en) | B cell epitope polypeptide of trichina intestinal cysteine protease inhibitor, hybridoma cell strain, monoclonal antibody and application | |
Lu et al. | Cloning, expression and functional characterization of a D-superfamily conotoxin Lt28. 1 with previously undescribed cysteine pattern | |
CN109797159B (en) | Recombinant expression protein of wheat yellow streak virus N gene, preparation method of polyclonal antibody and its application | |
CN101130775A (en) | A new signal conotoxin sequence, preparation method and application thereof | |
CN101962644A (en) | A kind of preparation method of porcine new gene BCL-GL polyclonal antibody | |
CN100404680C (en) | Duck B lymphocyte stimulating factor cDNA and its cloning method and recombination application | |
CN111018966B (en) | Hemibarbus maculatus insulin-like growth factor 3, its protein, its antibody and application | |
JP4300117B2 (en) | Tick galectin | |
CN103848888B (en) | A kind of people's C1Q/TNF α GAP-associated protein GAP 2(hCTRP2)Antigenic Peptide and its antibody | |
CN113736825A (en) | Recombinant drosophila cell line for expressing swine atypical pestivirus fusion protein and preparation method and application thereof | |
CN112458093A (en) | Encoding gene of grapevine oyster allergenic protein TM and application thereof | |
Liu et al. | Osiris9a is a major component of silk fiber in lepidopteran insects | |
CN110790833A (en) | Tick autophagy-related protein molecule ATG5 and application thereof | |
CN109608527B (en) | Specific gene PgWOX11 for detecting ginseng adventitious root stem cells, and detection method and application thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |